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EVALUATING THE EFFECTIVENESS OF A CONTINUOUS CLIENT FEEDBACK 
SYSTEM FOR PAROLEES REFERRED TO TREATMENT:  BENCHMARKING 
TREATMENT OUTCOMES 
 
Objective:  The purpose of the present study was to evaluate the effectiveness of a group 
substance abuse program that incorporated continuous client feedback into treatment for 
parolees who had been referred to attend by the criminal justice system. 
Method:  The pre-post treatment outcomes, as measured by the Outcome Rating Scale 
(ORS; Miller & Duncan, 2000), of 1,112 diverse parolees participating in treatment from 
October 2014 to January 2015 were analyzed.  The most up-to-date benchmarking 
methodology was utilized to compare treatment outcomes observed in the naturalistic 
setting with those observed in rigorous randomized controlled trials evaluating the 
Partners for Change Outcome Management System (Duncan, 2012, 2014; Duncan & 
Sparks, 2010).  Two sets of benchmarks were constructed for comparison purposes: one 
each for the feedback and treatment as usual conditions for two studies of PCOMS in a 
group setting and one each for the feedback and treatment as usual conditions for all six 
PCOMS studies.   
Results: Compared to the feedback condition benchmarks, the average treatment effect 
size estimate of psychotherapy for the present sample (d = 0.59) was not found to be 
clinically equivalent to the average effect size estimate from the two PCOMS group 
studies or to the effect size estimate constructed from all six PCOMS studies.  In regards 
to treatment as usual, the effect size estimate from the present sample was found to be 
clinically superior to treatment as usual from all six PCOMS studies, including the two 
group randomized controlled trials.     
Conclusions: Despite the documented success in treatment outcomes regarding the use of 
continuous client feedback with voluntary clients, results suggest more modest effects 
with individuals referred to treatment.  Although not found to be equivalent with the 
feedback conditions from randomized controlled trials, the use of client feedback with the 
present sample resulted in outcomes superior to those of treatment as usual in the six 
PCOMS studies.  Particular characteristics of offender populations that can impact 
psychotherapy, and potentially treatment outcomes, are discussed.     
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Chapter One: Introduction and Review of Selected Literature 
Due to the high prevalence rates of substance use among offenders, they are often 
mandated or referred to attend substance abuse treatment.  Group therapy is the most 
frequently used format for both voluntary and involuntary substance abuse treatment 
(Blume, 1985).  However, studies evaluating the effectiveness of group therapy with 
offenders (Morgan & Flora, 2002) and substance abuse treatment for offenders (Anglin, 
Prendergast, & Farabee, 1998; Howard & McCaughrin, 1996; Klag, O’Callaghan, & 
Creed, 2005; Young, 2002) have yielded mixed results. 
Two salient characteristics of psychotherapy with offenders coerced to attend 
therapy that can potentially undermine treatment are resistance to therapy and lack of 
motivation.  Client feedback, a process in which the client’s perception of therapy 
progress is routinely assessed, has been proposed as a way to improve treatment outcome.  
Client feedback allows the therapist to be responsive to clients who are not responding to 
treatment and provides a platform for collaboration (Duncan, 2012).  Systems for 
tracking client progress have been found to improve treatment outcomes for both 
individuals (Lambert et al., 2001; Lambert et al., 2002; Miller, Duncan, Brown, Sorrell, 
& Chalk, 2006; Reese, Norsworthy, & Rowlands, 2009; Whipple et al., 2003) and 
couples (Anker, Duncan, & Sparks, 2009; Reese, Toland, Slone, & Norsworthy, 2010).  
Evidence of the effectiveness of client feedback in group settings is emerging, and a 
thorough search of the literature failed to find any studies that have evaluated the use of a 
client feedback system with offenders referred to attend group treatment.  Such a study 
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appears warranted given the positive results of research on continuous client feedback 
conducted with voluntary clients. 
Prevalence of Substance Abuse Among Offenders 
Imprisonment, probation, and parole are the most common forms of punishment 
and rehabilitation for individuals who are found to directly violate the established laws of 
society. The most recent data presented by the Bureau of Justice Statistics (Glaze & 
Kaeble, 2014) reported that at the end of 2013, nearly 7 million individuals were under 
correctional supervision in the United States.  Although this number has declined slightly 
since previous years, approximately one out of every 35 adults, or 2.9% of the total 
population, is either incarcerated, on probation, or on parole.  A closer examination 
reveals that 1 in every 51 adults in the United States was supervised in the community on 
either parole or probation, and 1 in every 110 adults was incarcerated in either a prison or 
jail (Glaze & Kaeble, 2014).  Lifetime substance use and substance use in the month prior 
to conviction are common characteristics of individuals under correctional supervision. 
   A national survey of adults on probation (Mumola & Bonczar, 1995) reported 
that nearly 70% disclosed some previous drug use in their lifetime, and approximately 
32% reported drug use in the month prior to the offense that resulted in probation.  A 
2002 survey of men and women in local jails found that 68% of inmates were found to be 
dependent upon or abusing alcohol and/or drugs, and 55% of convicted inmates reported 
having used drugs in the month prior to their offense (Karberg & James, 2005).  By 2004, 
state prisoner reports of prior drug use were 83%, whereas 79% of federal prisoners 
reported prior substance use (Mumola & Karberg, 2006).  The 2013 National Survey on 
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Drug Use and Health (Substance Abuse and Mental Health Services Administration, 
2014) reported 27.4% of adults on parole or other supervised release from prison at some 
time during the past year and 31.4% of adults on probation at some time during the past 
year were currently using illicit drugs.  Due to the prevalence of individuals under the 
influence of a substance at the time of the offense and the prevalence of lifetime 
substance use among offenders, corrections often incorporates substance abuse treatment 
into the inmate, probationer, or parolee’s rehabilitation plan.   
Based on the point in the legal process where the individual is pressured to enter 
into substance abuse treatment, coercion from the criminal justice system can take several 
forms (Klag et al., 2005).  Though no longer heavily relied upon, civil commitment is 
considered to be the most coercive form for the individual is required to attend treatment 
in a secure facility for an extended period of time (Farabee & Leukefeld, 2001).  More 
commonly, an individual may be coerced into treatment in exchange for a deferred, 
reduced, or lifted sentence.  Individuals may also be required to complete treatment as a 
condition of probation or parole (Rotgers, 1992).  Despite the prevalence of substance use 
among offenders and the frequent use of coercive treatment, studies examining the 
effectiveness of such treatment have generated inconsistent results.   
Effectiveness of Substance Abuse Treatment for Offenders 
Despite the abundance of research on coerced substance abuse treatment for 
offenders, results regarding the effectiveness of such treatment have been mixed (Anglin 
et al., 1998; Howard & McCaughrin, 1996; Klag et al., 2005; Young, 2002).  Researchers 
maintain inconsistencies in study findings can be partly attributed to conceptual and 
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methodological problems including a lack of consistent terminology, the failure of early 
research to differentiate between the various treatment settings in which coercion can be 
applied, the lack of consideration of individual difference factors that can potentially 
impact outcomes, failure to consider the interaction of coercion and motivation, and a 
failure to differentiate between various levels of coercion (Anglin et al., 1998; Young, 
2002).   
In regards to inconsistent terminology within the existing literature on work with 
involuntary clients, definitions used when describing this particular population can vary 
greatly from one article to the next.  For example, the terms “criminal justice referred,” 
“mandated,” “coerced,” “compulsory,” and “involuntary” are often used interchangeably 
and with differing definitions from one article to the next (Anglin et al., 1998).  
Unfortunately, no universal criteria are available within the field to explicitly differentiate 
this particular group of clients from those who seek services voluntarily.  
Regardless of inconsistencies in the findings, coerced treatment for substance 
abuse is often a common component of rehabilitation plans for individuals under 
correctional supervision.  Many researchers have found that such therapy can be an 
effective means of treatment with outcomes similar to or even better than voluntary 
substance abuse treatment (Anglin et al., 1998; Brecht, Anglin, & Dylan, 2005; Kelly, 
Finney, & Moos, 2005; Staton-Tindall et al., 2009).   
Anglin, Prendergast, and Farabee (1998) reviewed 11 studies published from 
1976 to 1996 that examined the effectiveness of various levels of coercion (i.e., legal 
pressure) for substance abuse treatment for drug-abusing offenders.  Four of the studies 
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found no differences in outcomes between individuals who entered into treatment under 
some level of legal pressure and those who entered voluntarily or under minimal levels of 
coercion (Anglin, Brecht, & Maddahian, 1989; Brecht & Anglin, 1993; McLellan & 
Druley, 1977; Simpson & Friend, 1988).  Five of the 11 studies reported finding greater 
outcomes (e.g., completion rates, attendance, retention, criminality, and/or substance use) 
for individuals who entered into treatment under some level of legal coercion when 
compared to those who entered into treatment voluntarily (Collins & Allison, 1983; 
Rosenberg & Liftik, 1976; Salmon & Salmon, 1983; Schnoll, Goldstein, Antes, & 
Rinella, 1980; Siddall & Conway, 1988).  For example, Collins and Allison’s (1983) 
study of 2,276 individuals in outpatient and residential treatment programs found that 
clients who were legally referred for treatment remained in therapy longer than did those 
who did not experience legal pressure.  Only two of the 11 studies reported finding worse 
outcomes (e.g., compliance or retention) for those who entered into treatment under some 
level of legal coercion when compared to those who entered voluntarily (Harford, 
Ungerer, & Kinsella, 1976; Howard & McCaughrin, 1996).  It is important to note that 
the only statistically significant difference found by Harford et al. (1976) was that 
treatment retention was poorer for older methadone clients and adolescents admitted to 
treatment while on probation.  No other statistically significant differences in retention or 
completion rates (i.e., graduation of program) were found for any of the four measures of 
legal pressure (being on probation, being on parole, awaiting trial, or a composite of three 
previous groups).  Howard & McCaughrin (1996) found that treatment organizations with 
75% or greater court-mandated clients reported a statistically greater rate of clients failing 
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to follow the treatment plan.  However, no statistically significant differences were found 
for the completion of treatment goals between organizations with 75% or greater 
mandated clients and organizations with 25% or fewer mandated clients.  Results of 
Anglin et al.’s (1998) review provide support for the claim that individuals who 
experience legal pressure to enter substance abuse treatment generally experience 
outcomes similar to or better than those of individuals who entered into treatment 
voluntarily. 
Four other studies (Brecht et al., 2005; Burke & Gregoire, 2007; Kelly et al., 
2005; Staton-Tindall et al., 2009) also found coerced treatment for substance abuse to be 
effective.  A study conducted by Brecht et al. (2005) found no statistically significant 
differences on methamphetamine use outcome measures between those who felt 
pressured to attend treatment from either the criminal justice system or child protective 
services and those who did not perceive pressure.  Staton-Tindall et al.’s (2009) study 
examined substance use treatment outcomes for 700 offenders from Kentucky’s 
corrections-based substance abuse modified therapeutic community treatment programs 
using a pre-post design.  Results revealed that a significantly smaller percentage of 
participants reported any illicit substance use at follow-up than at baseline (43.9% versus 
94.1%, respectively; p < .0001).  Kelly, Finney, and Moos (2005) sought to examine 
differences between the characteristics, treatment processes, and one- and five-year 
outcomes for substance use disorder patients involved with the criminal justice system 
and mandated to treatment (JSI-M), involved with the justice system and not mandated to 
treatment (JSI), and not involved with the justice system (No-JSI).  Overall, there were 
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significant improvements during the course of treatment in coping, self-efficacy, and 12-
step group involvement.  At one-year follow-up, participants in the JSI-M group were 
significantly more likely to be abstinent (as measured by self-report and drug testing for a 
subset of participants; p < .001), in remission (p < .001), and to not have encountered any 
substance-related rearrests (p = .04) than members of both the JSI and No-JSI groups.  
Burke and Gregoire (2007) also conducted a self-report study examining the relationship 
between treatment coercion and post-treatment substance use and substance use severity 
for men enrolled in outpatient programs throughout Ohio.  Results revealed clients 
coerced into treatment had lower substance use severity scores at 6-month follow-up than 
did those participants who entered treatment voluntarily, controlling for pretreatment 
substance use severity.  Participants who were legally coerced into treatment also 
reported less substance use at follow-up than did those who entered without legal 
pressure.   
Several noteworthy limitations are present in the aforementioned studies.  
Participants were overall predominantly white males and assessment of motivation for 
treatment was not included in two of the studies (Brecht et al., 2005; Staton-Tindall et al., 
2009).  Staton-Tindall et al.’s (2009) study also did not include a comparison group or an 
assessment of perceived coercion for treatment.  With the exception of the study by Kelly 
et al. (2005), all studies utilized only self-report measures of substance use.  Despite the 
limitations of the aforementioned studies, coerced substance abuse treatment for 
offenders appears to produce treatment outcomes that are at least comparable to, if not 
greater than, those of individuals who enter into treatment voluntarily.    
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Group therapy for substance abuse.  Group counseling is the most frequently 
used treatment intervention for substance use disorders (Barlow, Burlingame, & 
Fuhriman, 2000; Blume, 1985) in order to allow group participants to develop supportive 
interpersonal relationships with others who have faced similar experiences, cultivate 
socializing techniques, and learn to identify problematic behavior patterns and 
appropriate coping strategies (Weiss, Jaffee, de Meni, & Cogley, 2004; Yalom, 2005).  
Group therapy also provides a cost effective way to maximize therapeutic services.  
Therapists are able to provide treatment to multiple clients in relatively the same amount 
of time as an individual session.   
Weiss, Jaffee, de Meni, and Cogley (2004) synthesized the research on group 
treatment for substance use disorders, identifying three studies (Graham, Annis, Brett, & 
Venesoen, 1996, Marques & Formigoni, 2001, & Schmitz et al., 1997) that directly 
examined the effectiveness of group therapy compared to individual therapy.  In each of 
the three studies, no significant differences were found in treatment outcomes based on 
the format of therapy.  One study found that individuals in the group therapy condition 
reported fewer days of cocaine use during treatment than did those participating in 
individual therapy (Schmitz et al., 1997).  Weiss et al. concluded that virtually identical 
treatments for substance use disorders delivered in either an individual or group therapy 
format generated no statistically significant differences on outcome measures.  For 
example, Schmitz et al.’s (1997) study of 32 cocaine-dependent participants assigned to 
either a group-based or individually-based relapse prevention program found no 
statistically significant differences between drug tests based on format of treatment nor 
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any significant difference on cocaine use outcome measures.  Individuals in the group-
format reported significantly fewer cocaine-related problems and significantly fewer days 
of cocaine use during treatment than did participants who received individual therapy.  
The authors concluded that relapse prevention treatment for cocaine abuse was effective 
regardless of format. 
Group therapy for offenders.   Studies have started to evaluate the effectiveness 
of group therapy formats for offender populations, yet results thus far have been 
inconsistent (Morgan & Flora, 2002).  A national survey of group therapy in state 
correctional facilities reported an average of 20% of male inmates of responding 
therapists received some type of group treatment.  Of male inmates receiving group 
therapy services, an average of 54% were referred by staff or mandated to attend 
(Morgan, Winterowd, & Ferrell, 1999).  Morgan and Flora (2002) identified 26 studies 
meeting inclusion criteria for a meta-analysis of existing research examining the effects 
of group psychotherapy with incarcerated offenders.  Positive treatment effects were 
found for group therapy compared to control conditions for the variables of institutional 
adjustment (g = 0.43), anger (g = 0.45), anxiety (g = 0.94), depression (g = 0.57), 
interpersonal functioning (g = 0.36), locus of control (g = 0.79), and self-esteem (g = 
0.31).  Whether an inmate was mandated to attend treatment or attended on a voluntary 
basis was a non-significant predictor of effect size.  For studies in which clients 
volunteered for treatment, the weighted mean effect size was d = 0.68 (SE = 0.14) and for 
studies in which clients were mandated to attend, the weighted mean effect size was d = 
0.60 (SE = 0.22).  The authors concluded that group psychotherapy treatment with 
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offenders resulted in improvements of all outcomes assessed when compared to offenders 
in control conditions (Morgan & Flora, 2002).      
Despite the prevalence of research examining the effectiveness of coerced 
substance abuse treatment for individuals under correctional supervision, a thorough 
review of the literature failed to find any studies that examine the effect of a continuous 
client feedback system on therapeutic outcomes with such a sample.  Since previous 
research has found the use of continuous client feedback to be an effective means for 
improving psychotherapy outcomes for voluntary clients, an examination of the 
effectiveness of monitoring coerced clients’ response to treatment and the therapeutic 
relationship appears warranted.  Such practice would also align with Garvin’s (1997) 
third principle of group work with involuntary clients which encourages leaders to 
involve the client in group-related decision making as much as possible.  Prior to further 
exploration of this particular gap in the literature, use of client feedback with voluntary 
clients and the unique characteristics of therapy with coerced individuals will be 
reviewed.   
Client Feedback 
Continuous outcome assessment, or client feedback, entails the use of a 
psychotherapy outcome measure during each session of treatment, as opposed to the 
usual pre-post therapy format (Lambert, 2001).  In an era of accountability, the use of 
client feedback to track progress and outcomes is consistently becoming a more common 
practice in the field of psychotherapy and is considered to be a strategy for quality 
improvement (Lambert, 2010).  The client, clinician, parent, peer, or caregiver can 
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complete the outcome measures, which can be either diagnosis-specific or more general 
assessments of global functioning.     
Despite the fact that psychotherapy is a highly effective means of treating clients 
(Lambert, 2013), outcome studies also suggest that approximately 5-10% of clients 
deteriorate in therapy (Lambert & Ogles, 2004; Lambert & Shimokawa, 2011) and 
clinicians are generally unsuccessful at predicting treatment failure (Breslin, Sobell, 
Buchan, & Cunningham, 1997; Chapman et al., 2012; Hannan et al., 2005; Yalom & 
Lieberman, 1971).  Additionally, clinicians generally over estimate the success of their 
clients in the progression towards and attainment of treatment goals (Walfish, McAlister, 
O’Donnell, & Lambert, 2012).  Thus, the use of client feedback has become an effective 
means of gathering information from the client on her or his perception of treatment 
success or failure.  By providing a real-time comparison to an expected treatment 
response, clinicians can more accurately gauge client progress (Duncan & Reese, 2015).  
With the monitoring of client perceptions on a regular basis, the opportunity is made 
available to engage in open communication with the client regarding progress and to 
better understand the client’s views of treatment.  The use of such feedback measures 
alerts therapists to client deterioration and signals when change is not occurring as 
predicted, offering the opportunity to address the client’s concerns in a practical and 
appropriate manner.  Recognizing, acknowledging, and discussing the client’s 
perceptions of treatment can potentially reduce instances of treatment failure (Reese et 
al., 2009).  The use of continuous client feedback has a well-established and increasing 
evidence base for improving treatment outcomes with adults in individual, couple, and 
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group therapy when compared to treatment-as-usual (Anker et al., 2009; Reese et al., 
2009; Reese et al., 2010; Schuman, Slone, Reese, & Duncan, 2015; Shimokawa, 
Lambert, & Smart, 2010; Slone, Reese, Mathews-Duvall, & Kodet, 2015).    
  A positive alliance during therapy is found to be one of the best predictors of 
successful outcomes, and the client’s perception of the therapeutic relationship is found 
to be the most consistent predictor of client improvement (Bachelor, 1991; Gurman, 
1977; Horvath & Symonds, 1991; Martin, Garske, & Davis, 2000).  Second only to the 
client’s own strengths and resources (e.g., social support, motivation to change), the 
therapeutic alliance is considered to be the most consistent predictor of client outcome 
(Duncan, Miller, Wampold, & Hubble, 2010; Horvath & Symonds, 1991; Lambert, 1992; 
Lambert & Ogles, 2004; Martin et al., 2000; Wampold, 2001).  The therapeutic alliance 
is a partnership between the therapist and the client that is made up of three interrelated 
elements, including the client’s sense of connection with the therapist, the client and 
therapist’s agreement on the goals of treatment, and agreement between the client and 
therapist on the tasks of treatment (Bordin, 1979).  Thus, the frequent monitoring of the 
client’s perception of the alliance and treatment outcome via the use of a continuous 
client feedback system would appear to be a beneficial and informative practice.     
Continuous assessment in therapy.  Two commonly used continuous client 
feedback systems, the Outcome Questionnaire System (OQ System; Lambert, Hansen, & 
Harmon, 2010) and the Partners for Change Outcome Management System (PCOMS; 
Duncan, 2012, 2014; Duncan & Sparks, 2010), are described below.  Although there are 
currently several formal feedback systems in the field (see Castonguay, Barkham, Lutz, 
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& McAleavey, 2013), only the OQ System and PCOMS have been evaluated via 
randomized clinical trial (RCT) design in the United States.  Both feedback systems are 
a-theoretical (i.e., common factors) and assess global functioning, as opposed to 
diagnosis-specific concerns (Duncan, 2012).   
Due to the significant improvements demonstrated in clinical settings, both 
feedback systems have been included on the Substance Abuse and Mental Health 
Services Administration’s (SAMHSA) National Registry of Evidence-Based Programs 
and Practices (SAMHSA, 2012).  Both feedback systems are also congruent with the 
definition of evidence-based practice in psychology established by the Presidential Task 
Force on Evidence Based Practice of the American Psychological Association (APA):  
“[T]he integration of the best available research with clinical expertise in the context of 
patient characteristics, culture, and preferences” (APA Presidential Task Force on 
Evidence-Based Practice, 2006, p. 274).  Further information on each system is provided 
and reviewed below.       
Outcome Questionnaire System (OQ System).  Lambert and colleagues (1996) 
were among the first in the field to develop and implement a formal system for obtaining 
client feedback.  The OQ System, which is composed of the Outcome Questionnaire-45 
(OQ-45; Lambert et al., 2013), was developed to monitor client status and progress 
during the course of therapy on domains including personal distress, difficulties in 
interpersonal relationships, and problems related to one’s social roles.  The OQ-45, which 
is a 45-item measure of global distress that takes approximately 5-7 minutes to complete, 
is generally administered to the client at the commencement of each therapy session.  
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Scores can range from 0 to 180 with lower scores signifying less distress.  The cutoff 
score for the OQ-45 demarcating dysfunction/normal functioning is 63/64.  The OQ 
System also includes a signal alarm system that uses statistical algorithms to monitor 
progress and alert therapists to instances when clients are not-on-track (NOT; i.e., at risk 
for negative outcome or premature termination of therapy).  If a client is identified as 
being NOT, the Assessment for Signal Clients (ASC), a 40-item self-report measure 
aimed at assessing the type and severity of problems that may be impacting treatment 
progress, can be implemented.  The items correspond to subscales regarding the 
therapeutic alliance, client motivation and readiness for change, diagnostic formulation, 
life events, need for medication referral, and social support.  Subscales are associated 
with corresponding recommendations for adjusting treatment to resolve identified 
problems.  The ASC is presented within the framework of the clinical support tools 
(CST), which provide the therapist with a decision tree and possible interventions to aid 
in problem solving and responsiveness to the client (Lambert, 2015).   
Evidence for the efficacy of the OQ System is based on nine RCT studies, all of 
which demonstrated significant treatment gains for clients identified as being NOT who 
were in a feedback (FB) condition compared to those receiving treatment as usual (TAU; 
Crits-Christoph et al., 2012; Harmon et al., 2007; Hawkins, Lambert, Vermeersch, Slade, 
& Tuttle, 2004; Lambert et al., 2001; Lambert et al., 2002; Probst et al., 2013; Slade, 
Lambert, Harmon, Smart, & Bailey, 2008; Simon et al., 2013; Whipple et al., 2003).  
Shimokawa, Lambert, & Smart’s (2010) meta/mega-analysis evaluating the effects of the 
OQ System was conducted with six of the earliest RCT studies, each of which examined 
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the effects of providing feedback about each client’s (N = 6,151) improvement via the use 
of progress graphs and a signal alarm system for NOT cases.  When the odds of 
deterioration and obtaining clinically significant improvement were compared, 
individuals in the FB condition had 2.6 times higher odds of experiencing reliable 
improvement (i.e., an improvement of at least 14 points) and less than half the odds of 
experiencing deterioration compared to individuals receiving TAU.  Estimated weighted 
mean effect sizes were computed (Hedge’s g), with negative values indicating lower 
levels of distress.  The intent-to-treat (ITT) analyses comparing mean post-test OQ-45 
total scores for those receiving feedback with those receiving TAU for individuals 
identified as NOT resulted in the following aggregated between-group effect sizes:  g = -
0.28 (p < .01) when feedback was only provided to the therapist, g = -0.36 (p < .001) 
when feedback was provided to both the therapist and the client, and g = -0.44 (p < .001) 
when feedback was provided to the therapist along with CST.  Additionally, the overall 
percentages of clinically significant improvement for clients identified as NOT were:  
30.9% when feedback was provided to the therapist only, 38.7% when feedback was 
made available to both the client and the therapist, and 37.6% when feedback was 
provided to the therapist and accompanied by CST.         
Using the meta-analysis conducted by Shimokawa et al. (2010), Lambert and 
Shimokawa (2011) further examined the efficacy of the OQ System by examining only 
those clients who completed treatment (as opposed to the ITT sample).  When NOT 
clients in the FB condition were compared to clients in the TAU condition, the meta-
analysis found a combined weighted random effect size for post-treatment OQ-45 score 
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difference of r = 0.25 (g  = 0.53; p < .001).  The meta-analysis also found the average 
client at-risk for treatment failure (i.e., NOT) whose clinician received feedback was 
better off than approximately 70% of NOT clients whose therapist did not receive 
feedback.  At termination, 9% of clients in the FB conditions deteriorated during 
treatment, as opposed to 20% in the TAU condition.  Additionally, at termination 38% of 
those identified as being NOT in the FB condition obtained clinically significant change 
(i.e., reliable change that includes moving from the clinical range to the nonclinical 
range), while only 22% from the TAU condition clinically significantly improved.  
 Despite the documented success of the OQ System in helping to improve clinical 
outcomes for clients who are identified as being NOT, therapists have noted that the 
amount of time needed to administer and score the OQ-45 has resulted in them not using 
it frequently in the therapy setting.  In addition, both clients and therapists have voiced 
concerns that many of the items on the measure are not relevant or pertinent to the 
reasons the client was attending therapy (Duncan, Miller, & Sparks, 2004).  In an attempt 
to remedy the concerns voiced by clients and therapists alike, a briefer, more feasible 
outcome system was developed.    
Partners for Change Outcome Management System (PCOMS).  Duncan, Miller, 
and Sparks (2004) maintain that to obtain the valuable information from the client 
regarding her or his perception of treatment progress and the therapeutic alliance on a 
regular basis requires fervent attention to the client’s goals, as well as the flexibility of 
the therapist to alter treatment based on ongoing assessments of the client’s perception of 
whether or not treatment is advancing in an expected and positive direction.  This 
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particular insight, coupled with a desire to address the concerns of the OQ System, helped 
to facilitate the development of a client-directed outcome-informed (CDOI) approach to 
treatment in which it is the client, not a specific model or intervention, that guides the 
therapy process.  The Partners for Change Outcome Management System (PCOMS; 
Duncan, 2012, 2014; Duncan & Sparks, 2010) is a continuous client feedback system that 
helps to meet the goals of a CDOI approach to therapy.  PCOMS was developed to help 
reduce client dropout and deterioration in therapy, as well as improve client outcomes.  
PCOMS is composed of the Outcome Rating Scale (ORS; Miller & Duncan, 2000) which 
measures the client’s well-being and the Session Rating Scale (SRS; Miller, Duncan, & 
Johnson, 2002) which measures the client’s perception of the therapeutic relationship.  
According to Sparks, Duncan, and Miller (2008), the undeniable link between the 
client’s positive ratings of therapist provided variables (i.e., warmth, professionalism, fit 
with the views and expectations of the client) and improved psychotherapy outcomes 
makes a strong case for a focus on fitting the therapy process to the client’s perceptions 
of a positive relationship.  Knowing the client’s perception of the treatment process and 
the therapeutic relationship is a key component in improved psychotherapy outcomes, 
routinely collecting and reviewing information from the client regarding both is 
warranted.  PCOMS aims to privilege the voice of the client during therapy and enables 
the client to share her or his views of treatment progress with the therapist.  
Despite having much briefer measures of client outcome and therapeutic alliance 
than the OQ System, PCOMS has also demonstrated its efficacy in clinical settings for 
individuals (Reese et al., 2009), couples (Anker et al., 2009; Reese et al., 2010), and 
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groups (Schuman et al., 2015; Slone et al., 2015).  Reese, Norsworthy, and Rowlands 
(2009) conducted RCTs in two sites to replicate the findings of Miller et al. (2006).  The 
sample for study one was 74 clients, the majority of whom identified as White and 
female, who attended individual therapy at a university counseling center.  The sample 
for study two was also 74 clients, the majority of whom also identified as White and 
female, who attended individual therapy at a graduate training clinic for a marriage and 
family therapy master’s program.  In the first study, participants were assigned to either a 
FB or TAU condition using a randomized block design to help control for therapist 
effects.  For study one only, clients in the FB condition completed the ORS at the start of 
each session and the SRS at the conclusion of each session.  Participants in the TAU 
condition completed the ORS only at the beginning and end of treatment, not at each 
session.  Protocol for study two differed in two primary ways:  (1) participants in the 
TAU condition completed the ORS at the start of each session of treatment (as opposed 
to only at the first and last session), and (2) therapists, rather than clients, were randomly 
assigned to the FB or TAU condition so as not to trouble beginning marriage and family 
therapy practicum students with the task of alternating between two therapy protocols.  
Results of the studies indicated that clients in the FB condition reported greater 
improvement than did those in the TAU condition.  Individuals in both treatment 
conditions showed statistically significant improvement on pre and post measures of the 
ORS.  In both studies the FB condition showed roughly twice as much improvement as the 
TAU condition (study one:  12.69 points vs. 6.82 points; study two:  10.83 vs. 4.69 
points).  Reese et al. (2009) found medium to large effect sizes according to Cohen’s 
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(1988) standards for the FB condition (study one: d = 0.54; study two: d = 0.49).  
Additionally, analyses of data from study two revealed that clients in the FB condition 
were estimated to achieve reliable change (at least a 5 point improvement on the ORS) in 
fewer sessions than those in the TAU condition.  Clients in the FB condition also 
demonstrated statistically significant higher rates of reliable change than did clients in the 
TAU condition (study one: 80% versus 54.2%; study two: 66.67% versus 41.4%).  This 
finding indicates that all clients in the FB condition, not just those clients identified as 
being NOT for reliable change, benefited significantly from therapy with PCOMS when 
compared to controls (Reese et al., 2009). 
Two RCT studies (Anker et al., 2009; Reese et al., 2010) have also demonstrated 
PCOMS’ efficacy in improving outcomes for couples’ therapy.  Anker, Duncan, and 
Sparks (2009) evaluated treatment outcomes of 205 couples assigned to either a FB or 
TAU condition.  The effect size for the difference between the FB condition and TAU 
condition was d = 0.50.  Over twice as much improvement was noted on the ORS for 
couples in the FB condition when compared with those in the TAU condition (8.27 vs. 
3.11 points).  Additionally, nearly four times as many couples in the FB condition 
obtained clinically significant change (reliable change that includes moving from the 
clinical range to the non-clinical range); effects were maintained at 6-month follow-up 
with in the FB condition significantly more likely to be together.  The aforementioned 
findings were replicated by Reese, Toland, Slone, and Norsworthy’s (2010) study of 46 
couples assigned to either a FB or TAU condition.  The standardized mean effect size 
between treatment conditions was d = 0.48.  Participants in the FB condition 
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demonstrated over twice as much improvement on the ORS (8.58 vs. 3.64 points).  As 
with the previous study, nearly four times as many couples in the FB condition achieved 
clinically significant change compared with those receiving TAU.  Additionally, clients 
utilizing PCOMS during therapy improved at a faster rate.   
Lambert and Shimokawa’s (2011) meta-analysis examined the overall efficacy of 
PCOMS by reviewing three RCT studies (Reese et al., 2009; Anker et al., 2009).  The 
analysis produced a combined weighted random effect size of r = 0.23 (p < .001) for post-
treatment scores of clients in the FB condition compared to clients receiving TAU.  
Results were comparable to research on the OQ System in which the combined effect size 
for the earliest six studies was r = 0.25 (p < .001).  Furthermore, when the odds of 
obtaining reliable improvement over the odds of not achieving reliable improvement 
were compared across conditions, individuals in the FB group had 3.5 times higher odds 
of experiencing reliable change and less than half the odds of experiencing deterioration 
(Lambert & Shimokawa, 2011).   
Continuous assessment in group therapy.  Evidence for the efficacy of 
continuous client feedback within group psychotherapy settings is emerging. Though 
feedback systems are theoretically posited to be effective in a group setting (Dies & Dies, 
1993), results are decidedly mixed (Davies, Burlingame, Johnson, Gleave, & Barlow, 
2008; Schuman et al., 2015).  Research examining the use of a client feedback system in 
such a setting is reviewed below.    
Davies, Burlingame, Johnson, Gleave, and Barlow (2008) examined the effect of 
client feedback on group process and outcome with group therapy clients at a university 
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counseling center.  Participants (N = 94) made up 16 psychotherapy groups that were 
randomly assigned to either a FB or TAU condition.  Participants completed the Curative 
Climate Instrument (CCI; Fuhriman, Drescher, Hanson, & Henrie, 1986) and the Group 
Climate Questionnaire - Short version (GCQ-S; MacKenzie, 1981) at the end of each 
group session.  Participants in the FB condition (both leaders and group members) were 
provided with a tally of the responses to the GCQ-S, which provides information on 
members’ sense of engagement, avoidance, and conflict.  The OQ-45 (Lambert et al., 
1996), which served as the outcome measure, was completed at the start and conclusion 
of treatment.  Analyses found no significant difference in outcome or engagement 
between the two conditions.  The authors speculated that even though the group members 
received general information regarding the group climate, the lack of specific information 
about themselves or others in the group provided only limited opportunity to gain 
interpersonal insight and information (Davies et al., 2008).   
The efficacy of PCOMS for group therapy has also been evaluated.  In the group 
format, the ORS is administered to all clients at the start of each session and the Group 
Session Rating Scale (GSRS; Duncan & Miller, 2007) to all clients toward the conclusion 
of each session.  As with the individual format, scores for each measure are totaled and 
charted to track progress.   
A 2015 study by Schuman, Slone, Reese, and Duncan evaluated the efficacy of a 
modified version of PCOMS with soldiers referred for group substance abuse treatment.  
Participants, who were primarily referred for treatment in the program by their 
commanding officer following some type of alcohol or drug-related problematic behavior, 
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were randomly assigned to either a group FB condition (n = 137) or a group TAU 
condition (n = 126).  Participants completed a computerized version of the ORS prior to 
each process group session.  The GSRS was not utilized in this study as it had not yet been 
developed at the time of data collection.  Therapist and commander outcome ratings were 
also obtained during a rehabilitation team meeting after completion of the soldier’s last 
therapy session.  Controlling for pretreatment functioning, an ANCOVA found a 
significant difference in post-ORS scores between treatment conditions (p = .011), 
indicating that the FB condition demonstrated larger treatment gains than the TAU 
condition.  A small-to-medium effect size (d = 0.28) was found for feedback.  Further, 
effects were found for all clients in the FB condition, not just those noted to be NOT or at 
risk for negative treatment outcomes.  Additionally, individuals in the FB condition also 
attended more therapy sessions and were less likely to terminate prematurely compared 
with those in the TAU condition.      
Slone, Reese, Mathews-Duvall, and Kodet (2015) utilized a randomized cluster 
design (in which groups as a whole were randomly assigned to a treatment condition) to 
evaluate the efficacy of PCOMS in a group psychotherapy format.  Group therapy 
participants (N = 84) were assigned to either a FB condition (n = 43) or a TAU condition 
(n = 41) at a university counseling center.  Participants attended an interpersonal process 
therapy group for social anxiety and interpersonal concerns.  Those in the FB condition 
completed the ORS at the start of every session and the GSRS at the conclusion of each 
session.  Participants in the TAU condition completed the ORS at the start of every 
session, but leaders were not provided access to members’ progress and leaders were 
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instructed not to prompt any discussion of the measures.  As in the aforementioned study 
evaluating PCOMS in a group setting, statistically significant pre-post treatment gains 
were found for feedback when compared to TAU; however, the magnitude of change for 
the Slone et al. study was slightly larger than that observed in the Schuman et al. (2015) 
study (d = 0.41 vs. d = 0.28).  The authors posited the differences might partially be 
attributable to use of the GSRS and length of group intervention.  Participants in the Slone 
et al. (2015) study attended an average of 10 weekly 1.5- hour sessions compared with an 
average of 3.86 sessions of the same length for the Schuman et al. (2015) study.  Although 
the results yielded a medium group effect size (Cohen, 1988), the effects of feedback in 
group settings appear to be more modest than from RCTs using PCOMS for individuals (d 
= 0.49 and d = 0.54; Reese et al., 2009) and couples therapy (d = .50 and d = .54; Anker et 
al., 2009; Reese et al., 2010).  Results indicated more clients in the FB condition than in 
the TAU condition obtained reliable change (32.6% vs. 17.1%) and clinically significant 
change (41.9% vs. 29.3%) on the ORS.  Clients in the FB condition also attended a higher 
number of sessions compared to those in the TAU condition (10.4 vs. 9.6).  No 
statistically significant differences were found between treatment conditions on premature 
termination rates.  
Various research studies have demonstrated that the use of continuous client 
feedback has proven effective in the reduction of premature termination and improved 
treatment outcomes.  Significant findings such as the ones described above have resulted 
in the APA’s Task Force for Evidence-Based Practice in Psychology (2006) 
recommendation that practice include the monitoring of treatment outcomes.   
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Despite the documented success of client feedback systems in improving 
treatment outcome, a thorough search of the client feedback literature failed to identify 
any studies that address the use of a continuous feedback system with offenders who have 
been referred or coerced to attend therapy.  The improved outcomes resulting from the 
use of a continuous client feedback system with voluntary clients, as well as the unique 
characteristics of work with individuals coerced to treatment, warrants an examination of 
the effectiveness of feedback with involuntary clients.   
Characteristics of Coerced Psychotherapy 
 Two particularly salient characteristics of psychotherapeutic work with 
involuntary clients include the referred individual’s potential resistance to treatment and 
motivation for therapy.  As will be reviewed below, both can undermine treatment.   
Client resistance.  The majority of authors in the field agree that involuntary 
clients generally enter into therapy with a greater degree of resistance than clients who 
seek services voluntarily (Rooney, 2009; Slonim-Nevo, 1996; Snyder & Anderson, 2009; 
Storch & Lane, 1989).  Resistance, which is considered by Norcross (2010) to be a 
reaction that is characterized by high defensiveness and responding in an oppositional 
manner to external demands, is a potential response for any individual who is forced or 
coerced into a situation.  Resistance, which is a barrier to the process of eliciting change 
in clients, is postulated to be more likely to occur when an individual perceives a loss of 
freedom of choice (Moyers & Rollnick, 2002).  Thus, resistance frequently manifests in 
work with non-voluntary and legally mandated clients who potentially perceive their 
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freedom of choice regarding the use of treatment to have been violated.  The involuntary 
and resistant client is described by Storch and Lane (1989): 
At the time when the mandated client appears at the Center, he is generally very 
upset and agitated.  He has likely just had some sort of difficulty which has 
brought him to the attention of some agency of society – court, probation or 
parole office, the police, child protection, school, and so forth.  Generally the 
agency has taken a look as the situation and has decided that “treatment” would 
be an effective part of the intervention.  On the basis of this decision the person is 
sent to an agency, center, or clinic of one sort or another.  He comes grudgingly, 
angry at the authority that “remanded” him to the Center, and hardened and 
reinforced in his anger and defiance.  Like the apocryphal child who, as low man 
in the family hierarchy kicks the dog, the mandated patient feels put upon and 
aggrieved, and lashes out at the available target (p. 30). 
Resistance is often considered to be a typical and fundamental response, as 
opposed to an indicator of pathology, for any individual who is coerced into 
psychotherapy treatment and who is consequently experiencing a perceived loss of 
freedom, independence, and choice (Moyers & Rollnick, 2002; Rooney, 2009; Snyder & 
Anderson, 2009; Storch & Lane, 1989).  Due to the normative nature of the concept, 
Rooney (2009) considers resistance to instead be a label applied by practitioners to 
clients who do not behave or act to the clinician’s satisfaction.  Moyers and Rollnick 
(2002) echo this belief by considering resistance to be a product of the interaction 
between the client’s attitudes and reaction to treatment and the clinician’s attitudes and 
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reactions to those of the client.  Thus, resistance potentially becomes a therapist variable 
as well as a client variable in involuntary treatment (Moyers & Rollnick, 2002).   
Several authors consider resistance to be such a normative reaction to an 
oppressive environment that they have renamed the term reactance in order to better 
capture the role the context of treatment plays in the client’s noncompliance (Beutler, 
Harwood, Michelson, Song, & Holman, 2011; Brehm & Brehm, 1981; Robinson & 
Davis-Kennington, 2002).  Brehm and Brehm (1981) theorized reactance inevitably 
results as a means by which to counteract one’s perceived loss of autonomy and choice.   
Client motivation.  Another important client factor in involuntary psychotherapy 
is the client’s level of motivation, defined broadly as that which moves the client to act 
(Ryan, Lynch, Vansteenkiste, & Deci, 2011).  Researchers in the field not only consider 
involuntary clients to have higher levels of resistance or reactance than voluntary clients, 
but also to have lower levels of motivation and initial readiness for change (Rooney, 
2009; Slonim-Nevo, 1996; Snyder & Anderson, 2009; Storch & Lane, 1989).  Motivation 
is considered to be a primary factor relevant to issues of dropout, treatment compliance, 
and maintenance of change in therapy (Drieschner, Lammers, & van der Staak, 2004; 
Overholser, 2005; Ryan & Deci, 2008).  One particular model of motivation that has 
specific applicability to psychotherapy is the transtheoretical model, which posits 
behavior change occurs over time as the individual progresses through a series of stages 
of change (Prochaska & DiClemente, 1986; Prochaska, DiClemente, & Norcross, 1992).  
The “stages of change were formulated as a fundamental part of a transtheoretical therapy 
 
 
 
 27 
model which has been developed as an integrative model of change for the fragmented 
field of psychotherapy” (McConnaughy, Prochaska, & Velicer, 1983, p. 368).  
Transtheoretical model of motivation to change.  The transtheoretical model of 
motivational readiness to change views the construct of motivation as existing along a 
continuum or in a spiral pattern, rather than as a dichotomy (Prochaska & DiClemente, 
1986; Prochaska et al., 1992).  The concept of readiness to change generally indicates a 
willingness of the client to adopt a particular behavior and has been conceptualized as a 
combination of the clients’ perceptions of the importance of the problem and the clients’ 
confidence in their ability to change (Miller & Rollnick, 2002; Rollnick, Mason, & 
Butler, 1999).  Five stages of motivational readiness exist and include:  (1) 
precontemplation (the client does not acknowledge a problem exists or is under-aware 
that a problem exists, and thus has no desire to change), (2) contemplation (the client is 
aware a problem exists and is seriously contemplating changing, but has not yet taken 
action), (3) preparation (the client is seriously considering changing in the next month 
and has perhaps taken small preparatory steps), (4) action (the client modifies her or his 
behavior, experiences, and/or environment), and (5) maintenance (the client works to 
prevent relapse).  Each stage of the model specifies motivational demands “by 
segmenting the change process into specific tasks to be accomplished and goals to be 
achieved, if movement toward successfully sustained change is to occur” (DiClemente, 
Schlundt, & Gemmell, 2004, p. 104).  Although individuals progress through the five 
stages at various rates, the tasks and goals of each stage of change are invariant.  The 
stages of change (representing when people change), processes of change (representing 
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how people change), decisional balance, and levels of attribution (to what the client 
attributes the problems) are the primary components of psychotherapy and behavior 
change (Brogan, Prochaska, & Prochaska, 1999; Prochaska & DiClemente, 1982, 1984, 
1992).  
Stages of change as predictor of treatment outcome.  Research has demonstrated 
that the stages of change and processes of change can reliably predict treatment outcomes 
in psychotherapy for a variety of presenting problems (Polaschek, Anstiss, & Wilson, 
2010), as well as predict treatment attendance (Prochaska, Norcross, Fowler, Follick, & 
Abrams, 1992) and treatment termination (Brogran et al., 1999).  Pretreatment motivation 
has also been found to predict the client’s engagement and retention in treatment (Joe, 
Simpson, & Broome, 1998).  A study conducted by Brogan et al. (1999) revealed that 
static client demographic characteristics (e.g. gender, age) were not significant predictors 
of termination or continuation of therapy, but the transtheoretical stages of change, 
processes of change (i.e., activities used by individuals to alter problem behaviors; 
Prochaska, Velicer, DiClemente, & Fava, 1988), and decision-making variables (i.e., 
factors that influence one’s opinions of entering into therapy) were able to reliably 
predict one’s therapy status.  Results indicate 75%, 69.2%, and 52.2% of clients in each 
category were correctly classified as premature terminators, appropriate terminators, or 
continuers of therapy, respectively.  Individuals who terminated therapy prematurely 
exhibited high precontemplation scores and low scores on the other stages of change.  
Individuals in the appropriate termination group demonstrated high scores on the action 
scale, while participants in the continuation group exhibited high scores on the 
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contemplation and maintenance scales with lower scores on the precontemplation and 
action scales.  When the appropriate termination and therapy continuer groups were 
combined, results indicated 97.2% of participants were correctly classified in the 
composite group and 83.3% were correctly classified as premature terminators (Brogan et 
al., 1999).   
Norcross, Krebs, and Prochaska’s (2011) meta-analysis of 39 studies revealed an 
effect size d = 0.46 for the ability of the client’s pretreatment stage of change to predict 
treatment outcome.  The medium effect revealed by the meta-analysis indicated that the 
amount of client progress during treatment tends to be a function of the client’s readiness 
to change.  The authors further analyzed the effect sizes of the stages of change based on 
specific diagnostic categories: eating disorders, mood disorders, and addictions.  For the 
14 studies predicting addiction outcomes using pretreatment readiness to change, the 
mean effect size was d = 0.37 (95% CI = 0.23-0.52, p < .001).  
Motivation for change models and coerced clients.  Research has only recently 
started to examine the application and utility of readiness for change models for coerced 
and incarcerated client samples (Hiller et al., 2009).  Results of initial studies have 
suggested, “treatment motivation also may be a predictor of retention, engagement, and 
outcomes from corrections-based treatment” (Hiller et al., 2009, p. 30).  Broome, Knight, 
Knight, Hiller, and Simpson’s (1997) study of 250 individuals on probation who were 
mandated by courts to a substance abuse treatment facility found that individuals’ 
recognition of drug related problems, as measured by client self-report and counselor 
ratings, was positively associated with therapeutic relationships during treatment.  Good 
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therapeutic relationships were negatively associated with rearrest (Broom, Knight, 
Knight, Hiller, & Simpson, 1997).  Research conducted by Hiller, Knight, Leukefeld, and 
Simpson (2002) with probationers mandated to residential substance abuse treatment 
found that clients’ desire for help and readiness for treatment were positively associated 
with indicators of therapeutic engagement, including higher levels of personal 
involvement and higher ratings of personal progress.  Other research has found a 
significant direct relationship between client pretreatment motivation, voluntary entry 
into aftercare services following release from prison, and reductions in reoffending and 
drug use (De Leon, Melnick, Thomas, Kressel, & Wexler, 2000).  
Clients falling into the precontemplation stage of the transtheoretical model of 
motivational readiness to change are most likely to be clients who were sent for therapy 
because of external pressure (i.e., force from others) (Prochaska et al., 1992).  Thus, 
based on the previously provided descriptions of involuntary clients, most would 
theoretically fall into the category of precontemplation.  DiClemente and Hughes (1990) 
have found precontemplators to be less motivated to change than are clients in the action 
and maintenance stages and precontemplators have also been found to be less likely to 
develop a strong therapeutic alliance during the course of treatment (Connors et al., 
2000).  Larke (1985) claims that successful work with involuntary clients is predicated on 
the ability of the therapist to not give up on the relationship with the client due to her or 
his resistance or lack of motivation.  Snyder and Anderson (2009) theorize a lack of 
motivation is potentially a normal and expected reaction for precontemplators forced into 
treatment who experience a double bind when acknowledging a problem exists.   
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McConnaughy, Prochaska, and Velicer’s (1983) initial work on the stages of 
change in psychotherapy produced seven major and two minor client profiles, including 
the Reluctance cluster.  Individuals falling into this particular category generated close to 
average scores on Pre-Contemplation and Contemplation, with Maintenance scores 
falling below average and Action scores falling “extremely below average” (p.373).  The 
authors concluded that individuals categorized in this minor cluster are unwilling to take 
action on the problem, although there may be some acknowledgement that a problem 
does, in fact, exist.  Individuals in the Reluctance profile do not exhibit any commitment 
to change.  Individuals comprising the Reluctance category were speculated to have 
entered into treatment because of family, employer, or legal pressures rather than for 
internal motivation to change.  The authors hypothesized that such clients would be more 
likely to prematurely terminate therapy or, if they do continue, would be resistant during 
the treatment process.    
Larke (1985) maintains motivation for treatment does exist in the involuntary 
client, but perhaps in a manner that is different and more vague from the motivation in 
the client who voluntarily seeks treatment.  It is recommended that the therapist ask for 
what is the involuntary client motivated as opposed to whether or not the involuntary 
client is motivated.  For example, when working with a client who was ordered to 
counseling for driving while intoxicated, the client’s motivation may be to simply get her 
or his driver’s license back after it was revoked.  Though this goal or form of motivation 
is likely not ideal in the eyes of the clinician and the referring agency who would 
undoubtedly prefer more meaningful behavior change (i.e., no longer driving while 
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intoxicated), the client’s goal nonetheless serves as a source of motivation.  Wampold et 
al.’s (1997) meta-analysis of outcome studies attributes 87% of improvement during 
therapy to client variables, which include motivation and readiness to change. 
Statement of the Problem 
Because of the strong empirical support for the use of client feedback with 
voluntary individuals and the unique characteristics and circumstances that underlie 
coerced treatment with offenders, it appears the use of a formal system for monitoring 
outcome and alliance would be imperative.  However, as previously mentioned, a 
thorough search of the client feedback literature failed to find studies that have assessed 
the effectiveness of using a continuous client feedback system, specifically PCOMS, with 
a sample of offenders who have been referred to attend treatment.  The aforementioned 
study conducted by Schuman et al. (2015) found a small-to-medium effect size (d = 0.28) 
for feedback when a modified version of PCOMS was utilized for soldiers referred to 
group substance abuse treatment.  Based on the positive results shown with voluntary 
clients and the results of the Schuman et al. (2015) study with referred soldiers, it appears 
a study examining the effects of feedback for referred offenders would be warranted.  It is 
hypothesized that the use of a continuous feedback system with clients referred to 
treatment by the criminal justice system would help to privilege their voices and provide 
them with a sense of power and self-determination in an environment in which they 
otherwise potentially experience feelings of coercion and a perceived loss of autonomy.  
When involuntary clients experience resistance and decreased motivation for treatment, 
the use of a feedback system in which their views and perceptions are prioritized could 
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potentially result in increased motivation and readiness for change, as well as better 
therapeutic outcomes.  Client feedback offers the possibility of improving referred 
clients’ treatment motivation and readiness for change through the continuous monitoring 
of outcome and alliance.  It is hypothesized that such a process would improve client 
engagement in therapy, and consequently motivation for treatment and therapeutic 
outcomes.   
Based on the importance of the client’s perceptions of treatment outcome, it is 
strongly recommended that research in the field focus on the effectiveness of continuous 
client feedback measures with this particular population of clients.  It is believed that by 
providing ongoing and direct feedback to the therapist, the client will experience 
increased treatment gains and lower rates of dropout or deterioration.     
A unique opportunity exists within the Georgia State Board of Pardons and 
Paroles to address this particular gap in the literature.  Because the Parolee Substance Use 
Recovery Program currently employs a continuous outcome assessment system 
(PCOMS) and collects data from group members during each session (via the ORS and 
GSRS), this study offers the possibility to add to the forensic psychological literature by 
evaluating the effectiveness of a substance abuse treatment program for offenders 
referred to attend.   
Purpose of the current study and research questions.  The purpose of the 
present study was to evaluate the effectiveness of an outpatient substance abuse treatment 
program for parolees that utilizes a continuous client feedback system as a quality 
improvement strategy.  The current study implemented benchmarking methodology to 
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evaluate the effectiveness of services provided to parolees who have been referred to 
attend outpatient substance abuse treatment at a Georgia State Board of Pardons and 
Paroles counseling program that implements PCOMS.   
 Utilizing the most up-to-date benchmarking methodology (Minami, Serlin, 
Wampold, Kircher, & Brown, 2008), the present study seeks to examine the following 
research question: in comparison to efficacy trial benchmarks, is group psychotherapy 
utilizing continuous client feedback (i.e., PCOMS) effective among parolees who have 
been referred to attend treatment?  Following guidelines presented in previous 
benchmarking studies (e.g., Minami, Wampold, Serlin, Kircher, & Brown, 2007), results 
from clinical trials will be used to construct treatment group and control group 
benchmarks (i.e., separate aggregated effect size estimates for clients receiving treatment 
or in a TAU condition, respectively).  The effectiveness of group treatment provided to 
parolees will be evaluated by comparing the observed pre-post effect size estimate 
against the established efficacy benchmarks.  It is hypothesized that the treatment 
provided to parolees in the corrections-based setting will be equivalent to treatment 
efficacy observed in clinical trials and superior to TAU.   
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Chapter Two: Method 
The present study is an evaluation of the effectiveness of a group substance abuse 
program that incorporates continuous client feedback into treatment for parolees who 
have been referred to attend by the Georgia State Board of Pardons and Paroles.  In this 
chapter, the current sample will be detailed and the procedures and treatment outcome 
measure will be reviewed.  Benchmarking methodology, as well as the construction of 
the specific benchmarks, will then be described.  Next, a detailed description of the data 
analyses, including the calculation of effect sizes and benchmarking procedures will be 
provided.  Lastly, each hypothesis will be specified.   
Design 
 The current naturalistic study utilized a benchmarking design to evaluate the 
effectiveness of a corrections-based program utilizing a continuous client feedback 
system with parolees who have been referred for substance abuse treatment.  
Benchmarking allows for the direct statistical comparison of pre-post outcome data 
obtained from non-controlled, naturalistic settings with rigorous and reliable outcome 
standards observed in single clinical trials or meta-analyses of clinical trials (Minami et 
al., 2007; Minami, Serlin, et al., 2008; Weersing & Weisz, 2002).  Effectiveness of a 
particular treatment is established by assessing whether the benefits to clients in a natural 
setting approach the benefits obtained by clients in clinical research.  Benchmarking 
methodology allows for this evaluation without altering any aspects of the treatment 
delivered in the clinical setting (Minami, Wampold, et al., 2008).  The magnitude of 
change observed in clinical trials (efficacy studies) is used as a benchmark against which 
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the magnitude of change observed in the naturalistic setting is judged (Wade, Treat, & 
Stuart, 1998). 
 Benchmarking methodology from Weersing and Weisz (2002) and Minami, 
Serlin, Wampold, Kircher, and Brown (2008) was used to guide the present study.  
Methodology was advanced in several ways by the work of Weersing and Weisz (2002).  
The treatment being offered in the naturalistic setting was not altered during evaluation, 
which allowed for the results to be generalized to TAU in the same setting.  The authors 
also utilized a benchmark effect size derived from the meta-analysis of multiple studies, 
as opposed to only a single or a few studies, in order to provide a more comprehensive 
and thorough comparison.  A wait-list/control benchmark was also established in order to 
compare treatment to the natural history or remission of symptoms over time.  Lastly, the 
authors evaluated whether the effect size from the naturalistic setting fell within the two-
tailed 95% confidence interval of the clinical trial based benchmark effect size.  This 
provided for a more rigorous comparison than previous methodology that simply 
subjectively compared the two values.  A further advancement by Minami, Serlin, et al. 
(2008) included the use of the “good-enough principle” (Serlin & Lapsey, 1985, 1993), 
which establishes a relevant margin between the effect size from the naturalistic setting 
and the established benchmark.  This statistical criterion for equivalence prevents one 
from obtaining statistical significance with clinically trivial differences.  The 
aforementioned advances in methodology have allowed for the analysis of other data sets, 
including the one utilized for the present study.     
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 Effect size (ES) estimates were calculated for the present sample of referred 
offenders and then compared against benchmarks (i.e., TAU and ITT) constructed from 
clinical trials examining the efficacy of continuous client feedback.  Effectiveness studies 
are conducted in naturalistic settings with effects for pre-post change typically being 
based on all clients in treatment, as opposed to only those who completed treatment.  
Thus, the conditions are more comparable to ITT ESs from efficacy research, which 
include all participants who were initially randomized into conditions and not just those 
who completed the treatment protocol (i.e., treatment completers).  Additionally, because 
naturalistic settings rarely offer the opportunity for comparisons to a no-treatment control 
group, due to practical and ethical reasons, the use of a treatment as usual group 
benchmark will allow for effectiveness testing with a comparison group (Minami et al., 
2007).   
Procedures 
 The Institutional Review Board (IRB) at the University of Kentucky approved the 
present study through an expedited review process on June 24, 2015.  The Georgia State 
Board of Pardons and Paroles (GSBPP), which contracts with Spectrum Health Systems 
(SHS), a private, not-for-profit organization that provides mental health and substance 
abuse services, provided pre-existing treatment outcome data.  Through their partnership, 
the GSBPP and SHS provide weekly outpatient group psychotherapy for individuals 
across the state of Georgia who have been referred by the criminal justice system to 
substance abuse treatment (risk-based referral from the individual’s parole officer).  
Individuals who are referred to treatment attend an initial 90-minute intake group session 
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referred to as Motivation Assessment and Planning (MAP).  During the initial session, 
group members assess personal risk and need factors, as well as set goals and tasks for 
the remaining sessions.  Following completion of the initial session, the individual is 
placed in a Recovery Action and Progress (RAP) group that meets weekly for 60 
minutes.  RAP groups, which include a maximum of 10 participants, are based upon the 
“what works (i.e., evidence-based practices)” literature for offender rehabilitation.  
Groups are cognitive-behavioral in design and consist of motivational assessment and 
planning.  Sessions focus on discussing and processing one’s progress, goals, resources, 
and barriers.  In order to successfully complete the Parolee Substance Use Recovery 
Program, participants must attend at least six consecutive RAP group sessions and obtain 
at least two consecutive negative drug screens.  SHS included PCOMS in the treatment of 
all parolees involved in this study.     
Treatment providers utilized PCOMS comprehensively across the state, 
administering the ORS at the commencement of each session and the GSRS at the 
conclusion of each session.  Group leaders were trained in administration of the measures 
via a 6-8 hour in-person training and follow-up PCOMS webinars.  In regards to 
continuous quality improvement strategies, clinicians received written feedback from a 
clinical supervisor who observed a group session.  Observations were conducted in order 
to help ensure fidelity to PCOMS protocol, as well as to address any concerns or 
questions regarding group administration or use of the feedback system.  Feedback 
occurred quarterly to annually, depending on the clinicians’ experience and competence 
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(as deemed by the supervisor).  Clinicians (N = 55) were predominantly female (81.8%).  
No additional information was provided regarding clinicians’ demographics.               
Participants 
 For the present study, SHS and the GSBPP granted permission for data analysis of 
parolees who attended substance abuse treatment across the state of Georgia between 
October 2014 and January 2015.  The initial dataset included 3,250 cases, to which the 
following deletions were made:  (a) 944 cases in which only one session was attended, 
thus not allowing for the calculation of a pre-post change score, (b) 577 cases in which 
the individuals started treatment too late during the time period to complete the 
requirements, (c) 607 cases in which the individuals started treatment prior to the time 
period for which data was provided, thus an initial (pretest) score was not available, and 
(d) ten cases in which the individuals were discharged from the program by the parole 
officer (due to a transfer or the completion of the parole term).  In order to be included in 
the analysis, the individual had to attend at least two sessions, with the first being the 
MAP intake session, in order to calculate a pre-post change score.  Of the 607 cases in 
which treatment was started prior to the time period for which data were provided, 269 
cases included a REC 1 score, but not a MAP score.  Please see the Preliminary Analyses 
section of the Results chapter for a comparison regarding ORS scores for those with a 
MAP score at pretest and those with a REC 1 score at pretest.  Consistent with guidelines 
utilized by Reese, Duncan, Bohanske, Owen, and Minami (2014), if clients re-entered 
treatment, only the first observation was included in analyses.  As some benchmarking 
studies only utilized clients in analyses who had an initial intake score in the clinical 
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range (e.g., Minami et al., 2009; Stiles, Barkham, Connell, & Mellor-Clark, 2008), the 
present study included clients whose functioning at intake (i.e. the MAP session) was in 
the non-clinical range.  This was consistent with methodology utilized by Reese et al. 
(2014) and allowed for the data set to be more representative of individuals referred for 
treatment in the Parolee Substance Use Recovery Program.    
After the aforementioned deletions were made, the final dataset contained 1,112 
individuals.  Please see Table 1 for complete sociodemographic information of the 
present sample.  The majority of individuals in the final dataset were African American 
(49.6%), male (82.9%), employed (54.1%), unmarried (65.9%), and ranged in age from 
18 to 68 years (M = 35.42, SD = 10.22).  Additionally, in regards to education, the 
majority of participants had at least completed high school or obtained a GED (45.0%).  
Of those who had not yet completed high school or obtained a GED, 84.80% (n = 385) 
had completed at least the ninth grade.  Parolees were conditionally released from 
incarceration to serve the remainder of the sentence in the community.  Of those 
individuals included in the final dataset, 34.9% had been incarcerated for a drug related 
offense (i.e., drug possession, possession with intent to distribute, drug trafficking, 
sale/distribution of a controlled substance), making it the most common offense category.  
All individuals included in the present study participated in the Parolee Substance Use 
Recovery Program between October 2014 and January 2015.  Of those who participated 
in treatment, 48.9% (n = 544) successfully completed the program (i.e., attended at least 
six consecutive group therapy sessions and obtained at least two consecutive negative 
drug screens).  Individuals who had to restart the program due to a positive drug screen (n 
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= 155), primarily tested positive for marijuana (69.03%), with cocaine (16.13%) and 
methamphetamine (14.84%) being the next two most common substances identified; 
23.23% tested positive for more than one substance.  
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Table 1 
Client Demographic Information  
 Full                                       
sample 
 (N = 1,112) 
Age M (SD, Range)  35.42 (10.22, 50) 
Sex  
        Male n (%) 922 (82.9) 
        Female n (%) 99 (8.9) 
        Sex Unknown n (%) 91 (8.2) 
Race/Ethnicity  
        African American n (%) 551 (49.6) 
        Euro-American n (%) 452 (40.6) 
        Latino(a)/Hispanic n (%) 12 (1.1) 
        Other Ethnicity n (%) 6 (0.5) 
        Unknown Race/Ethnicity n (%) 91 (8.2) 
Employment Status  
        Employed n (%) 602 (54.1) 
        Unemployed n (%) 419 (37.7) 
        Employment Unknown n (%) 91 (8.2) 
Marital Status  
        Unmarried n (%) 733 (65.9) 
        Married n (%) 132 (11.9) 
        Divorced n (%) 109 (9.8) 
        Separated n (%) 32 (2.9) 
        Widowed n (%) 12 (1.1) 
        Marital Status Unknown n (%) 94 (8.5) 
Education (Highest Level Completed)  
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Table 1 Continued  
        Some Grade School n (%) 454 (40.8) 
        High School/GED n (%) 399 (35.9) 
        Some Technical Education n (%) 11 (1.0) 
        Completed Technical Degree n (%) 2 (0.2) 
        Some College n (%) 83 (7.5) 
        Bachelor’s Degree n (%) 5 (0.4) 
        Education Unknown n (%) 158 (14.2) 
Major Offense   
        Drug Related Offenses 389 (35.0) 
        Violent Offenses (not previously included) 168 (15.1) 
        Burglary Offenses 143 (12.9) 
        Theft Offenses 106 (9.5) 
        Weapons Offenses 62 (5.6) 
        Robbery Offenses  55 (4.9) 
        Interference/Obstruction/Fleeing Offenses  45 (4.0) 
        Fraud/Forgery/Financial Offenses 37 (3.3) 
        Other Offenses 12 (1.1) 
        Unknown Offense 95 (8.6) 
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Measure 
Outcome Rating Scale (ORS).  The ORS (Miller & Duncan, 2000; see Appendix 
A) is an ultra-brief self-report outcome measure that is to be administered to the client at 
the beginning of each session in order to assess client progress throughout the course of 
therapy.  The client is asked to place a hash mark on each of four different ten-centimeter 
visual analog lines to indicate her or his level of well-being or distress over the past week 
on each domain.  Marks to the left of the visual analog line indicate more distress or less 
well-being on the particular domain, while marks to the right of the visual analog line 
indicate less distress or more well-being on the domain.  Three of the domains of client 
functioning, which were derived from the OQ-45 (Lambert et al., 1996), include 
“Individually” (the client’s view of her or his personal well-being or symptomatic 
distress), “Interpersonally” (relational distress or the client’s satisfaction with close 
relationships), and “Socially” (the client’s view of work/school and relationships outside 
of the home).  An “Overall” (general sense of well-being) scale was also included on the 
ORS.  The recorded distance for each of the four domains is then measured to the nearest 
millimeter, totaled, and charted on a graph (see Appendix B).  Total scores can range 
from 0 to 40.  Once the score has been totaled and recorded, the clinician can then discuss 
the marks, as well as any changes in scores, with the client.  The measure is available in 
paper-and-pencil or electronic format, as well as in multiple languages.     
In order to attribute increases in ORS scores over time to therapy, the difference 
between any two measurements must exceed the reliable change index (RCI; Jacobson & 
Truax, 1991).  The RCI is a statistical formula that calculates the amount of change 
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needed for results not to be attributable to chance or to the expected normal maturation of 
the client.  An analysis of over 400,000 administrations of the ORS determined the RCI 
to be 6 points (Duncan, 2014).  Utilizing a clinical sample (n = 435) and a nonclinical 
community sample (n = 86), the clinical cutoff for the ORS was determined to be 25 
(Miller, Duncan, Brown, Sparks, & Claud, 2003).  Any score falling below the cutoff of 
25 is indicative that the client has responded to the items in a manner that is similar to 
other individuals seeking therapy (Miller & Duncan, 2004).  Thus, in order to achieve 
clinically significant change, a client must begin treatment with an ORS score of less than 
25, improve by a minimum of six points, and complete treatment with an ORS score 
equal to or greater than 25.    
Empirical evidence for the reliability and validity of scores generated by the ORS 
has been provided in four psychometric studies (Bringhurst, Watson, Miller, & Duncan, 
2006; Campbell & Hemsley, 2009; Duncan, Sparks, Miller, Bohanske, & Claud, 2006; 
Miller et al., 2003), in addition to the PCOMS manual (Duncan, 2011; Miller & Duncan, 
2004).  Across studies, Cronbach’s alpha (α) coefficients for ORS scores averaged .85 for 
clinical samples and .95 for non-clinical samples (Gillaspy & Murphy, 2011).  Three 
studies (Bringhurst et al., 2006; Campbell & Hemsley, 2009; Miller et al., 2003) have 
evaluated the concurrent validity of the ORS by comparing scores to the OQ-45 (Lambert 
et al., 1996), a more established outcome assessment.  The average bivariate correlation 
between the scores was .62 (range .53 to .75), indicating moderately strong concurrent 
validity (Gillaspy & Murphy, 2011).  Additionally, ORS scores have been found to be 
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sensitive to change for individuals in clinical samples, yet stable over time for those in 
nonclinical samples (Bringhurst et al., 2006; Duncan et al., 2006; Miller et al., 2003).     
 Feasibility in clinical practice is also an important factor to examine when 
considering the utility of a measure.  The ORS was developed to address several concerns 
with the OQ-45, including the length of time required to administer and score the 
measure (Duncan, Miller, & Sparks, 2004).  Miller, Duncan, Brown, Sparks, and Claud 
(2003) evaluated the feasibility of the ORS by comparing clinicians’ compliance rates for 
utilization of the ORS and the OQ-45 across two sites.  After a period of 12 months, the 
compliance rate for the OQ-45 was 25%, while that for the ORS was 89%.   
For the present study, a modified scoring procedure was utilized for the ORS.  
Treatment providers were trained and instructed to measure each visual analog line of the 
scale to the nearest centimeter, as opposed to millimeter, which resulted in a whole 
number score.  The PCOMS trainer implemented this procedure for simplicity during 
scoring and recording of the measures.  One additional study has utilized a modified 
administration and scoring of the measure (Miller et al., 2006).  The authors evaluated the 
use of PCOMS with a large sample (N = 6,424) of diverse clients who received treatment 
via a telephonic-based employee assistance program (EAP).  The ORS was administered 
orally, as opposed to the typical paper/pencil or electronic formats, due to the nature of 
the services being provided (i.e., telephonically).  Clients were asked to orally provide a 
rating from one to ten for each subscale of the ORS.  Client outcomes were compared 
between a FB condition and a benchmark TAU condition.  Results revealed that effect 
sizes for individual therapy doubled from the baseline period to the final evaluation 
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period, increasing from d = 0.37 to d = 0.79 when PCOMS with a signal alarm system 
was implemented.  While information regarding the reliability of ORS scores for this 
sample was not provided, an independent analysis of a sample of n = 15,778 from the 
EAP produced a Cronbach’s alpha (α) coefficient of .79.  Additionally, test-retest 
reliability at the second administration of the ORS with a sample of n = 1,710 was .53.   
Benchmarking Methodology 
According to Minami, Serlin, et al. (2008), benchmarking allows for effectiveness 
to be established by comparing whether the benefits obtained by clients in clinical 
practice approach the benefits obtained by clients in controlled research studies.  As 
practice-based observational research does not generally allow for the comparison of 
treatment groups to a control group, benchmarking techniques were developed to 
compare routinely monitored outcomes from clinical settings with reliable outcome 
standards observed in clinical trials.  The most up-to-date benchmarking methodology, 
which is increasingly being employed in effectiveness studies, was utilized in the present 
study (see Minami et al., 2009; Minami, Wampold, et al., 2008; Minami et al., 2007; 
Reese, Duncan, Bohanske, Owen, & Minami, 2014 for examples).   
According to Minami, Serlin, et al. (2008), the three steps required in the 
benchmarking methodology are as follows:  (a) construct the pre-post treatment 
benchmarks (i.e., ESs) from clinical trials, including benchmarks for wait-list controls or 
TAU groups and for those who started but did not complete treatment (i.e., intent-to-
treat), (b) estimate the effectiveness of the sample being evaluated using pre-post effect 
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sizes, and (c) statistically compare the ES estimates from the current sample (i.e., 
parolees referred to treatment) with those benchmarks established from the clinical trials.   
  Advancing on the existing benchmarking methodology, Minami, Serlin, et al. 
(2008) included use of the “good-enough principle” (Serlin & Lapsley, 1985, 1993), 
which allows for statistical testing with a range-null hypothesis, as opposed to a point-
null hypothesis, in order to prevent rejection due to a large N (i.e., Type I error).  Because 
increases in sample size can lead to increases in statistical power, using a point-null 
hypothesis test could potentially result in any difference from 0 being found statistically 
significant (Serlin & Lapsley, 1985, 1993).  Thus, in order to appropriately and more 
rigorously interpret comparisons, critical values will need to be calculated to statistically 
determine whether the treatment ES estimate obtained from the naturalistic setting is 
comparable to the efficacy benchmarks or greater than the waitlist control/TAU 
benchmarks (Minami et al., 2007).  Borrowing from previous benchmarking studies in 
which a large sample was analyzed (Minami et al., 2009; Minami, Wampold, et al., 2008; 
Reese et al., 2014), an a priori margin of difference of 10% was utilized.  Any 
differences between the naturalistic setting’s ESs and the respective benchmarks that are 
within 10% of the benchmarks (90-110%) would be considered statistically trivial (i.e., 
fail to reject the null hypothesis) using a Type I error rate of α = .05.   
As opposed to a traditional point-null hypothesis (e.g., H0 : δSURP = δITT, where 
δSURP is the true ES of the Parolee Substance Use Recovery Program (SURP) and δITT 
represents the true treatment efficacy benchmark from the intent-to-treat (ITT) samples of 
the clinical trials), a range-null hypothesis (H0 : δSURP ≤ δITT – 10%) is used, which 
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follows a non-central t-distribution (Serlin & Lapsley, 1985; 1993).  Critical values were 
calculated in order to statistically compare the ESs of the current Substance Use 
Recovery Program sample to the computed clinical trial benchmark ESs.  For example, a 
critical value is calculated for the lower bound of the 90-110% range of the clinical trail 
benchmark ES at dITT − 10%.  Thus, the null hypothesis should not be rejected if the 
difference is within 10%, while also maintaining an overall Type I error rate of α = .05.  
Specifically, if the Substance Use Recovery Program ES falls at or above 90% of the 
benchmark from clinical trials (i.e., benchmark minus 10%), the ES from the present 
sample can be considered clinically equivalent to the clinical trial benchmark.  For 
comparison against the TAU benchmarks, if the Substance Use Recovery Program ES 
falls within 110% of the TAU benchmarks (i.e., benchmark plus 10%), the Substance Use 
Recovery Program ES will be considered clinically equivalent to TAU.  In order to claim 
the ES estimate was superior to TAU, the ES will need to exceed 110% of the TAU 
benchmark, while also maintaining an overall Type I error rate of α = .05.   
Construction of benchmarks.  Pre-post benchmarks have been constructed from 
as little as one RCT (e.g., Lee, Horvath, & Hunsley, 2013), two RCTs (e.g., Merrill, 
Tolbert, & Wade, 2003; Wade et al., 1998), three RCTs (e.g., Curtis, Ronan, Heiblum, 
and Crellin, 2009; Reese et al., 2014), or several RCTs (e.g., Weersing & Weisz, 2002).  
Once selected for use in constructing the benchmark, clinical trials are combined using 
standard meta-analytic procedures (e.g., Becker, 1988; Hedges and Olkin, 1985).  Two 
sets of benchmarks were constructed for the present study:  (a) benchmarks from two 
RCTs utilizing PCOMS in a group setting and (b) benchmarks from all six PCOMS 
 
 
 
 50 
RCTs (studies examining individuals, couples, and groups).  Each set of benchmarks 
includes an efficacy benchmark from the pre-post treatment outcomes of RCT FB 
treatment groups, as well as a comparison benchmark from the pre-post scores of the 
RCT TAU condition.   
One primary consideration in the selection of clinical trials for inclusion in 
constructing the benchmarks is the use of studies that employ comparable or equivalent 
outcome measures.  When selecting specific outcomes to aggregate among multiple 
measures used in the studies, one must consider the matching of reactivity and specificity 
both among and between the clinical trials.  Because clinical trials may favor the use of 
certain outcome measures that are not necessarily feasible to implement in naturalistic 
settings, it becomes important to match the outcomes used for constructing the 
benchmark and for assessing treatment effectiveness on these two criteria.  Reactivity 
primarily pertains to and is determined by who reported the outcomes; this may be a 
clinician, the client, or an independent rater.  Outcomes measured by the client will have 
low reactivity, while those measured by an observer will have higher reactivity.  
Specificity refers to the extent to which an outcome measure assesses symptoms specific 
to a particular diagnosis as opposed to global functioning.  Diagnosis-specific measures 
are high in specificity, while measures of more broad symptoms of global distress are low 
in specificity (Minami et al., 2007).  The ORS, which is a self-report measure of overall 
functioning and was the outcome measure utilized by the Parolee Substance Use 
Recovery Program, is considered low in reactivity and low in specificity (LR-LS).  
Constructing the feedback benchmarks from RCT studies that employed the ORS as the 
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outcome measure and that utilized similar client feedback processes allowed for a more 
direct comparison between the clinical trial data and the naturalistic setting data.  Thus, 
the use of PCOMS RCT studies helped to negate the concerns that can arise when 
measures are not matched on reactivity and specificity.  
Client feedback benchmarks.  As there are at present no existing studies on the 
use of continuous client feedback with offenders referred to treatment, the benchmarks 
constructed for client feedback were derived from the best effort of equivalence.  Given 
this particular gap in the literature, client feedback benchmarks were constructed from the 
existing RCTs utilizing PCOMS (Anker et al., 2009; Reese et al., 2009; Reese et al., 
2010; Schuman et al., 2015; Slone et al., 2015), as they permitted a direct comparison to 
the outcome measure utilized in the present sample.  As some of the aforementioned 
studies were conducted with individuals (Reese et al., 2009) and couples (Anker et al, 
2009; Reese et al., 2010), two separate sets of benchmarks were constructed for client 
feedback.  The first set of benchmarks contained only those studies using PCOMS in a 
group setting (Schuman et al., 2015; Slone et al., 2015), while the second set of 
benchmarks was constructed from all six existing RCT PCOMS studies.  Each set of 
benchmarks contained one for the FB conditions and one for the TAU conditions.  Please 
see Table 2 and Table 3 for the reported means and standard deviations of the studies that 
were utilized in the construction of the PCOMS FB benchmarks and PCOMS TAU 
benchmarks, respectively. 
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Table 2 
Studies Utilized for Construction of PCOMS FB Benchmarks 
Study Type N Pretest Post-test d 
M SD M SD 
Anker et al. (2009) Couple 206 18.08 7.85 26.35 10.02 1.05 
Reese et al. (2009) 1 Individual 50 18.59 7.60 31.28 6.63 1.64 
Reese et al. (2009) 2 Individual 45 18.68 10.39 29.51 9.58 1.02 
Reese et al. (2010) Couple 54 23.34 9.15 31.92 7.15 0.93 
Schuman et al. (2015)* Group 137 22.42 10.01 28.28 9.46 0.58 
Slone et al. (2015)* Group 43 23.47 7.86 30.87 6.49 0.43 
Notes.  FB = feedback; N = sample size; d = [1 - (3/4n - 5)] [Mpost - Mpre/SDpre]; M = 
Mean; SD = Standard Deviation; ORS = Outcome Rating Scale; * = study utilized for 
construction of PCOMS group setting benchmark.
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Table 3 
Studies Utilized for Construction of PCOMS TAU Benchmarks 
Study Type N Pretest Post-test d 
M SD M SD 
Anker et al. (2009) Couple 204 18.58 7.03 21.69 8.69 0.44 
Reese et al. (2009) 1 Individual 24 22.71 9.70 29.53 7.26 0.74 
Reese et al. (2009) 2 Individual 29 19.64 6.46 24.33 7.51 0.70 
Reese et al. (2010) Couple 38 24.03 9.47 27.67 9.53 0.37 
Schuman et al. (2015)* Group 126 20.43 9.56 24.57 10.30 0.43 
Slone et al. (2015)* Group 41 22.02 7.06 27.26 6.85 0.73 
Notes.  TAU = treatment as usual; N = sample size; d = [1 - (3/4n - 5)] [Mpost - 
Mpre/SDpre]; M = Mean; SD = Standard Deviation; ORS = Outcome Rating Scale; * = 
study utilized for construction of PCOMS group setting benchmark. 
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Offender treatment benchmarks.  A systematic search of the literature was 
conducted utilizing the Academic Search Complete, MEDLINE, Psychology and 
Behavioral Sciences Collection, PsycINFO, and Sociological Collection databases.  
Keywords utilized in the search included group psychotherapy, group therapy, group 
counseling, inmate, offender, prison, prisoner, parole, parolee, substance use, substance 
use disorder, and substance abuse.  Results were limited to scholarly/peer-reviewed 
articles published since 2000.  The aforementioned search parameters resulted in 84 
distinct articles.  Studies were excluded if they did not use a RCT design, did not employ 
a comparable outcome measure (LR-LS) assessing global functioning, did not focus on 
outpatient group substance abuse treatment for adults, and did not provide means and 
standard deviations for the entire (i.e., ITT) sample in order to calculate ESs.  
Additionally, studies were excluded if they focused on adolescents or female offenders 
only, as the present sample was primarily composed of adult males, or if they focused on 
a specific type of offense (e.g., sex offenses, domestic violence offenses).  The systematic 
search of the extant clinical trial literature did not result in any RCT studies that met 
criteria for inclusion in construction of the offender substance abuse treatment 
benchmark.   
The literature search did result in one meta-analytic synthesis of research on the 
effect of incarceration-based drug treatment on recidivism (Mitchell, Wilson, & 
MacKenzie, 2007).  The reference list of this article was examined for any additional 
studies that could potentially meet inclusion criteria; no studies were found.  One 
additional meta-analysis was found that examined the effects of CBT therapy for 
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substance abuse (Magill & Ray, 2008).  This analysis was examined for possible 
inclusion; however, outcomes utilized were related to substance use reduction (e.g., days 
abstinent, rate abstinent, days used), not general well-being.  Additionally, Taxman’s 
(2011) chapter from Leukefeld, Gullotta, and Gregrich’s (2011) text on evidence-based 
substance abuse treatment in criminal justice settings was examined for potential studies 
for inclusion that focus on parole samples.  Of the studies noted in the overview of 
existing literature for parolee substance abuse treatment, only one (Burke, Arkowitz, & 
Menchola, 2003) noted outcomes other than substance use, crime reduction, treatment 
utilization, or treatment retention.  As such, Burke, Arkowitz, and Menchola’s (2003) 
meta-analysis was examined for possible inclusion as a comparison benchmark.  
However, the study only included clinical trials of therapy delivered in an individual, as 
opposed to group, format.  
Based on the paucity of research meeting the aforementioned inclusion criteria, 
the literature search was modified to include general group therapy for offenders, as 
opposed to specifically substance abuse group treatment.  A systematic search of the 
literature was conducted using the aforementioned databases and the following keywords:  
group counseling, group therapy, group psychotherapy, offender, parole, inmate, 
prisoner, well-being, outcome, and efficacy.  The aforementioned search parameters 
resulted in 142 distinct articles.  Similar exclusion criteria were employed, with the 
exception of a focus on substance abuse treatment.  The systematic literature search again 
resulted in zero RCT studies for use in construction of the offender treatment benchmark.  
However, the search did result in two systematic reviews of group treatment for 
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offenders; these articles were examined for studies meeting inclusion criteria.  The 
reviews conducted by Morgan and Flora (2002) and Duncan, Nicol, Ager, and Dalgleish 
(2006) were examined, as were the reference lists from the articles.  The reviews did not 
include only RCT studies; the RCT studies that were included in the analyses were 
examined for possible use in construction of a benchmark.  However, no comparable 
RCT studies were found.      
Client feedback benchmark effect size calculations.  After the selection of RCT 
studies for inclusion, the following client feedback benchmarks were calculated:  (a) FB 
ITT samples from two PCOMS group studies, (b) TAU from two PCOMS group studies, 
(c) FB ITT from all six PCOMS studies, and (d) TAU from all six PCOMS studies.  
Following the guidelines of Minami, Serlin, et al. (2008), for each clinical trial i, the 
unbiased pre-post Cohen’s d ES estimate was calculated using the formula 
 
where ni is the sample size, Mi, post is the post-treatment mean of the measure, Mi, pre is the 
pretreatment mean of the measure, and SDi, pre is the pretreatment standard deviation.  
 Following the calculation of individual ES estimates di for each study, they were 
aggregated across clinical trials to produce a single ES value that served as the 
benchmark.  ES estimates were aggregated using the meta-analytic formula and 
guidelines specified in Minami, Serlin, et al. (2008).  Specifically, the variance of each 
RCT di is estimated by the formula  
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where ni is the sample size, di is the ES estimate, and ri is the estimated correlation 
between the pretreatment and post-treatment scores of the outcome measure (Becker, 
1988).  
 After the ESs di are calculated for each study, they are aggregated into a single 
value which will serve as the benchmark ES using the formula  
 
, 
   
where the value of dB is considered fixed.  Four feedback benchmarks were constructed:  
Aggregated treatment ES were calculated for the FB (dFBgrp = 0.65) and TAU (dTAUgrp = 
0.50) samples from the two PCOMS group RCTs and for the FB (dFBall = 0.91) and TAU 
(dTAUall = 0.48) samples from all six PCOMS RCTs.  Please see Table 4 for the client 
feedback effect size comparisons. 
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Table 4 
Effect Size Comparisons for Client Feedback Studies 
Study N d 95% CI 
Current Study 1,112 0.59 [0.52, 0.66] 
PCOMS group studies 180 0.65 [0.46, 0.84] 
All PCOMS studies 535 0.92 [.80, 1.04] 
Notes.  Six total studies were evaluated for comparison; two evaluated group treatment.  
PCOMS = Partners for Change Outcome Management System; N = sample size; d = [1 - 
(3/4n - 5)] [Mpost - Mpre/SDpre]; M = Mean; CI = confidence interval. 
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Critical value calculation.  Because increases in sample size can lead to increases 
in statistical power, using a point-null hypothesis test could potentially result in any 
difference from zero being found statistically significant (Serlin & Lapsley, 1985, 1993).  
Thus, in order to appropriately interpret comparisons using a range-null hypothesis while 
maintaining an overall Type I error rate of α = .05, critical values were calculated.  
Following Minami, Serlin, et al. (2008), the benchmarking hypotheses rely on a 95th 
percentile test statistic (e.g., t(FB) ν,λ:.95 and t(TAU) ν,λ:.95), which follows a non-central t 
distribution with v = N – 1 degrees of freedom and a noncentrality parameter 𝜆 =  
√N(dFB – 10% ) or 𝜆 =  √N(dTAU + 10%).  The critical values for the feedback-related 
benchmarks were determined by a normal approximation of the distribution and resulted 
in (dcv(FBgrp) = 0.64) and (dcv(TAUgrp) = 0.60) for only the PCOMS group studies and 
(dcv(FBall) = 0.89) and (dcv(TAUall) = 0.58) for all PCOMS studies.  In other words, the 
critical values for the FB condition ESs are based on the lower bound of the 10 percent 
range of clinical equivalence, while the critical values for the TAU condition ES are 
based on the upper bound of the 10 percent range of clinical equivalence.   
Data Analysis 
 Means, standard deviations, and ESs were calculated for the full sample by study 
sample characteristics, including sex and ethnicity (see Table 5).   
Effect size calculation.  The pre-post ES (Cohen’s d) was calculated for the full 
sample using baseline (i.e., MAP score), endpoint (last observation), and standard 
deviation from client ORS scores.  Consistent with the ES calculation for clinical trials 
that was previously noted, the formula  
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was used to calculate the unbiased ES estimates for the full Substance Use Recovery 
Program sample, where n is the sample size, M is the mean of the measure, and SD is the 
standard deviation.  The calculation of the ES for the naturalistic setting sample allowed 
for comparison to the published efficacy studies in the benchmark ESs.  The variance of 
the current sample was also estimated and reported using  
 𝜎!(!)! =   
!(!!  !!)
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 + !!
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where ri is the estimated correlation between the pre- and post-treatment scores of the 
outcome measure (Becker, 1988).  The Pearson product-moment correlation coefficient 
for the present sample was calculated (r = 0.278).  As noted in Minami, Serlin, et al. 
(2008), the value utilized in the aggregation of effect sizes would also be utilized in the 
calculation of the variance of the current sample.     
 Benchmarking analyses.  Lastly, benchmarking analyses were conducted.  As 
previously mentioned, range-null hypotheses were utilized to compare the ES from the 
present sample (i.e., the Parolee Substance Use Recovery sample) to the selected clinical 
trial benchmarks.  Range-null hypotheses were utilized, as the use of point-null would 
have likely led to the false rejection of the hypotheses due to large sample sizes (i.e., 
Type I error).  As increases in sample size can lead to increases in statistical power, the 
use of a point-null hypothesis could potentially result in any difference from zero being 
found statistically significant (Serlin & Lapsley, 1985, 1993).  Thus, range-null 
hypotheses with an a priori 10% margin of difference were utilized to more rigorously 
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compare the Substance Use Recovery Program sample with the established benchmarks.  
The range-null hypothesis follows a non-central t statistic (Serlin & Lapsley, 1985, 1993) 
and a normal distribution in approximated.  Critical values associated with each 
benchmark, which represented the 95th percentile value of the non-central t-distribution, 
were calculated and employed (see detailed description above) in order to compare ESs.  
Clinical significance testing using the 10% margin of difference that surrounds the 
efficacy trial benchmarks and statistical testing that maintained an overall Type I error 
rate of α = .05 allowed for appropriate evaluation and comparison of the effectiveness of 
the Substance Abuse Recovery Program with established clinical trials.   
 Benchmarking against client feedback conditions.  In order for the Substance 
Use Recovery Program sample ES to be considered clinically equivalent to the ITT 
feedback efficacy benchmark for the PCOMS group studies dCV(FBgrp), the present sample 
ES needs to exceed the critical value  
dCV(FBgrp) = 
!!,!:!"
!
, 
where 𝑡!,!:!"  is the 95th percentile value of the non-central t distribution and 𝜆 =
  √𝑁(𝑑!"(!"#$%) − 10%  ) is the noncentrality parameter.  Similarly, in order for the 
Substance Use Recovery Program sample ES to be considered clinically equivalent to 
ITT feedback efficacy benchmark for all PCOMS studies dCV(FBall), the present sample ES 
needs to exceed the critical value  
dCV(FBall) = 
!!,!:!"
!
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where 𝑡!,!:!"  is the 95th percentile value of the non-central t distribution and 𝜆 =
  √𝑁(𝑑!"(!"#$$) − 10%  ) is the noncentrality parameter. 
 Benchmarking against treatment-as-usual conditions.  Significance testing for 
comparison of the Substance Use Recovery Program ESs to the TAU conditions efficacy 
trial ESs is similar to the procedures outlined above; however, in regards to the non-
centrality parameter, -10% in the formula is replaced with +10%.  As such, the Substance 
Use Recovery Program sample ES estimate is considered statistically and clinically 
equivalent to a TAU condition in client feedback efficacy trials if it does not statistically 
significantly exceed the TAU benchmark at the 10 percent critical value.  Comparisons 
were made to the TAU conditions from only the group PCOMS studies and the TAU 
conditions from all PCOMS studies.   
Research Hypotheses 
 There are four primary hypotheses for the present study.  For the first two, it was 
hypothesized that the treatment outcomes for the Substance Use Recovery Program 
would be (a) clinically equivalent to efficacy outcomes observed in the feedback 
treatment conditions of the group only PCOMS studies and (b) clinically equivalent to 
the efficacy outcomes observed in the feedback treatment conditions of all PCOMS 
studies.  For the second two, it was hypothesized that the treatment outcomes for the 
current sample would be (a) clinically superior to the efficacy outcome observed in the 
TAU conditions of the group only PCOMS studies and (b) clinically superior to the 
efficacy outcomes observed in the TAU conditions of all PCOMS studies.  
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 Hypothesis one.  Utilizing range-null hypothesis testing guidelines from Serlin 
and Lapsley (1985, 1993) that were illustrated in Minami, Serlin, et al. (2008), when 
δ!"#$ is the true population ES estimate of the Substance Use Recovery Program (SURP) 
full sample (in Cohen’s d), δFBgrp is the true population client feedback efficacy 
benchmark from the PCOMS group studies (in Cohen’s d), and 10% is the maximum 
difference allowed to claim clinical equivalence, the range null and alternative 
hypotheses are:  
 H0 :  δSURP ≤ δFBgrp – 10% 
 H1 :  δSURP > δFBgrp – 10%. 
 Hypothesis two.  Similar to hypothesis one, utilizing the guidelines for range-null 
hypothesis testing that were outlined by Serlin and Lapsley (1985, 1993) and illustrated 
by Minami, Serlin, et al. (2008), when δ!"#$ is the true population ES of the present full 
sample (in Cohen’s d), δFBall is the true population client feedback efficacy benchmark 
from all PCOMS studies (in Cohen’s d), and 10% is the maximum difference allowed to 
claim clinical equivalence, the range-null and alternative hypotheses are: 
H0 :  δSURP ≤ δFBall – 10% 
 H1 :  δSURP > δFBall – 10%. 
 Hypothesis three.  The Substance Use Recovery Program ES estimate will be 
considered statistically and clinically superior to the TAU conditions in group client 
feedback efficacy trials if it statistically significantly exceeds the TAU benchmark at the 
10 percent critical value (i.e., exceeds the TAU comparison benchmark by 110%).  When 
δ!"#$ is the true population ES estimate (in Cohen’s d) of the Substance Use Recovery 
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Program sample, δTAUgrp is the true population ES estimate (in Cohen’s d) of the TAU 
efficacy benchmark from the PCOMS group studies, and 10% is the maximum difference 
allowed to claim equivalence, the range-null and alternative hypotheses are: 
H0 :  δSURP ≤ δTAUgrp  + 10% 
 H1 :  δSURP > δTAUgrp + 10%. 
Hypothesis four.  Similar to hypothesis three, if the Substance Use Recovery 
Program ES estimate exceeds the TAU comparison benchmark from all PCOMS studies 
by 110%, it will be deemed clinically superior to the established TAU benchmark.  Thus, 
when δ!"#$ is the true population ES estimate (in Cohen’s d) of the Substance Use 
Recovery Program sample, δTAUall is the true population ES estimate (in Cohen’s d) of the 
TAU efficacy benchmark from all PCOMS studies, and 10% is the maximum difference 
allowed to claim equivalence, the range-null and alternative hypotheses are: 
H0 :  δSURP ≤ δTAUall + 10% 
 H1 :  δSURP > δTAUall + 10%. 
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Chapter Three:  Results 
Preliminary Analyses 
The original data set (N = 3,250) contained 269 cases in which an initial 
Motivation Assessment and Planning (MAP) score was not provided, but a Recovery 
Action and Progress (RAP) session one score was recorded.  An independent samples t-
test was conducted to determine whether a statistically significant difference existed 
between the ORS pretest score for those individuals with a MAP score at pretest (n = 
1,112) and those individuals with a RAP session one score at pretest (n = 269).  Type of 
pretest score was the independent variable and initial ORS score was the dependent 
variable.  Results indicate a statistically significant difference in mean ORS pretest scores 
for those with a RAP session one score at pretest (M = 33.02, SD = 6.67) as compared to 
those with a MAP score at pretest (M = 31.26, SD = 6.68), t(1379) = 3.89, p < .001, d = 
0.26.  Similar results were obtained when the ORS pre-post change score was used as the 
dependent variable and type of pre-test score was used as the independent variable.  
Results of the independent samples t-test revealed a statistically significant difference in 
mean ORS change (pre-post) scores for those with a RAP session one score at pretest (M 
= 1.23, SD = 6.93) and those with a MAP score at pretest (M = 3.93, SD = 7.34), t(1379) 
= -5.46, d = 0.37.  As such, individuals without a MAP score but with a RAP session one 
pretest score were excluded from analyses.  
Average session numbers were calculated for the remaining sample.  The average 
number of sessions for the full Substance Use Recovery Program sample (n= 1,112) was 
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5.39, SD = 2.00.  Please see Table 5 for therapy outcomes by client demographic 
characteristics.    
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Table 5 
Therapy Outcomes by Client Demographics 
 Sample 
Size 
ORS Pre 
M (SD) 
ORS Post 
M (SD) 
Within Group  
d (95% CI) 
Female  99 31.58 (7.07) 35.72 (5.17) 0.58 [0.35, 0.81] 
Male  922 31.22 (6.66) 35.21 (5.30) 0.60 [0.52, 0.68] 
African American  551 30.38 (7.18) 34.68 (5.58) 0.60 [0.49, 0.71] 
Latino(a)/Hispanic  12 32.92 (6.69) 36.58 (3.12) 0.51 [-0.16, 1.18] 
Euro-American  452 32.20 (5.89) 35.94 (4.85) 0.63 [0.51, 0.75] 
Other Ethnicity  6 36.17 (6.21) 33.67 (7.55) 0.34 [-.020, 0.88] 
Notes.  N = 1,021; sex and ethnicity were not provided for 91 clients.  d = [1 - (3/4n - 5)] 
[Mpost - Mpre/SDpre].  ORS = Outcome Rating Scale; CI = confidence interval. 
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A multiple linear regression analysis was conducted in order to examine the 
predictive ability of demographic variables (i.e., age, sex, race/ethnicity, education level, 
employment, and marital status) and overall offense type on ORS pre-post change scores.  
Prior to analysis, all categorical variables with more than two values were dummy coded.  
The full model had an R2 = .020, F(23, 997) = .90, p = .61.  None of the selected variables 
statistically significantly predicted ORS pre-post change score.  Please see Table 6 for the 
correlations of each demographic variable with ORS pre-post change score and the 
regression weights.  Structure coefficients, or the correlations of the particular variable 
with the predicted score in the model, are also displayed in Table 6.     
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Table 6 
Correlations and Results from Multiple Regression Model 
Variable 
Correlation 
with ORS 
Change 
𝛽 rst 
Age  -.013 -.043 -.09 
Sexa .006 .002 .04 
Race/Ethnicity    
        Euro-American -.021 Reference Category 
        African American .051 .055 .31 
        Latino(a)/Hispanic -.004 -.004 -.04 
        Other -.065* -.059 -.49 
Education Level    
        High School/GED .052 Reference Category 
        Some Grade School -.010 -.039 -.15 
        Some Technical Education .017 .010 .12 
        Completed Technical Education -.011 -.020 -.08 
        Some College -.034 -.045 -.27 
        Bachelor’s Degree .004 -.001 .03 
Marital Status    
        Married      .045 Reference Category 
        Unmarried -.019 -.083 -.28 
        Separated -.015 -.037 -.13 
        Divorced .015 -.015 .08 
        Widowed .030 .027 .21 
Employmentb -.023 -.018 -.16 
Major Offense    
        Drug Related Offenses .006 Reference Category 
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Table 6 Continued    
        Violent Offenses (not previously included) .025 .018 .15 
        Burglary Offenses .011 .015 .05 
        Theft Offenses -.009 -.011 -.10 
        Weapons Offenses -.039 -.047 -.32 
        Robbery Offenses  -.015 -.025 -.13 
        Interference/Obstruction/Fleeing Offenses  .030 .023 .20 
        Fraud/Forgery/Financial Offenses .001 -.002 -.01 
        Other Offenses .033 .036 .24 
Notes. ORS = Outcome Rating Scale.  rst = structure coefficient. 
a 0 = male, 1 = female.  b 0 = not employed, 1 = employed. 
* p < .05 
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Results of Client Feedback Benchmark Hypotheses 
 The following results are based on the full Parolee Substance Use Recovery 
Program sample.  The mean pretreatment and post-treatment ORS scores for the full 
sample (N = 1,112) were Mpre = 31.26 (SD = 6.68) and Mpost = 35.18 (SD = 5.42), 
respectively, producing an observed standardized pre-post mean change of dSURP = 0.59 
(see Table 7) with a variance of .001.  As previously reported, all analyses utilized critical 
values with a Type I error rate of α = 0.05.   
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Table 7 
Critical Value Comparisons for Client Feedback Benchmarks 
 Feedback 
Benchmark 
(group  
PCOMS) 
TAU 
 Benchmark 
(group  
PCOMS) 
Feedback 
Benchmark 
(all  
PCOMS) 
TAU 
Benchmark  
(all  
PCOMS) 
SURP d dcv                p dcv                p dcv               p dcv               p 
 
0.59 
 
0.64          .441 
 
   0.60          .110 
 
  0.89         .999 
 
0.58          .028 
Notes.  SURP = Substance Use Recovery Program; PCOMS = Partners for Change 
Outcome Management System; TAU = treatment as usual; d = [1 - (3/4n - 5)] [Mpost - 
Mpre/SDpre]; dcv = critical effect size value required to attain statistical significance. 
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Hypothesis one.  The first specified hypothesis was that the ES estimate for the 
full Substance Use Recovery Program sample (dSURP = 0.59; N = 1,112) would be 
statistically and clinically equivalent to efficacy outcomes observed in the FB treatment 
conditions of the group only PCOMS studies.  Compared against the group only PCOMS 
FB benchmark (dFBgrp = 0.65) with a 10% a priori margin (dFBgrp[90%] = 0.59) and a 
critical value dCV(FBgrp) = 0.64, the observed Substance Use Recovery Program effect size 
estimate was not considered clinically equivalent (t = 19.67, df = 1,111, 𝜆 = 19.51, p = 
.44) to the FB treatment outcomes from the two group only PCOMS studies.  The 
estimated effect of the Substance Use Recovery Program sample did not exceed the 
magnitude of effect deemed necessary in order to claim at least clinical and statistical 
equivalence with the FB treatment outcomes from the two group PCOMS RCTs.   
 Hypothesis two.  The second hypothesis was that the ES estimate for the full 
Substance Use Recovery Program sample (dSURP = 0.59; N = 1,112) would be statistically 
and clinically equivalent to efficacy outcomes observed in the FB treatment conditions of 
all PCOMS studies.  Compared against the constructed benchmark for the FB conditions 
of all PCOMS studies (dFBall = 0.92) with a 10% a priori margin (dFBgrp[90%] = 0.83) and 
a critical value dCV(FBgrp) = 0.89, the observed Substance Use Recovery Program effect 
size estimate was not considered clinically equivalent (t = 19.67, df = 1,111, 𝜆 = 27.61, p 
= .999) to the established benchmark.  In other words, the estimated effect of the 
Substance Use Recovery Program sample did not exceed the established critical value 
(dCV(FBgrp) = 0.88) necessary in order to claim at least clinical and statistical equivalence 
with the FB treatment outcomes from all PCOMS RCTs.   
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 Hypothesis three.  The third hypothesis posited the ES estimate for the full 
Substance Use Recovery Program sample (dSURP = 0.59; N = 1,112) would be clinically 
and statistically superior to the constructed TAU benchmark from the two PCOMS group 
clinical trials.  Compared against the TAU benchmark from the PCOMS group studies 
(dTAUgrp = 0.50), given a 10% a priori margin of difference (dTAUgrp [110%] = 0.55) and a 
critical value dCV(TAUgrp) = 0.60, the observed Substance Use Recovery Program ES 
estimate was not considered clinically superior (t = 19.67, df = 1,111, 𝜆 = 18.34, p = 
.110).  In other words, the estimated effect of the Substance Use Recovery Program 
sample did not exceed the established magnitude of effect necessary in order to claim 
clinical superiority to TAU from the two PCOMS group studies.   
 Hypothesis four.  The fourth hypothesis specified that the ES estimate for the full 
Substance Use Recovery Program sample (dSURP = 0.59; N = 1,112) would be clinically 
superior to the TAU benchmark constructed from all of the PCOMS RCTs.  Compared 
against the TAU benchmark (dTAUall = 0.48), given a 10% a priori margin of difference 
(dTAUgrp [110%] = 0.53) and a critical value dCV(TAUgrp) = 0.58, the observed Substance 
Use Recovery Program ES estimate was statistically significant (t = 19.67, df = 1,111, 𝜆 
= 17.61, p < .001), suggesting that treatment provided via the Substance Use Recovery 
Program was clinically superior to the TAU group outcomes from all PCOMS RCTs.  
Supplemental Analyses 
 Several supplemental analyses were conducted in order to gain a better 
understanding of the effectiveness of the Parolee Substance Use Recovery Program.  The 
results of the secondary analyses are discussed below.   
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Clinical significance.  As was previously reviewed, the ORS was determined to 
have a reliable change index (RCI) of six points or more and a clinical cutoff score of 25 
for adults aged 18 years and over (Duncan, 2014).  Thus, by combining the RCI and the 
clinical cutoff score, one is able to examine the rates of reliable and clinically significant 
change.  An individual is considered to have obtained reliable change if the pre-post ORS 
change score was at least six points.  Furthermore, an individual is considered to have 
achieved clinically significant change if the initial ORS score below was below 25, there 
was a pre-post ORS change score of at least six points, and the post ORS score was at 
least 25.  Examining the rates of reliable and clinically significant change is another 
means by which to examine and understand clinical effectiveness.  For the full Substance 
Use Recovery Program sample, the rate of reliable change was 37.77% (n = 420) and the 
rate of clinically significant change was 11.60% (n = 129).  Additionally, 6.92% (n = 77) 
of the full sample reliably deteriorated during treatment, meaning there was a decrease of 
at least six points from the baseline measure.  Of those who experienced deterioration, 
22.08% (n = 17) attended only two treatment sessions. 
Clinical cutoff analysis.   A supplemental analysis was conducted to examine the 
effectiveness of treatment for individuals (n = 170) who had an initial ORS score below 
the clinical cutoff of 25.  According to Miller and Duncan (2004), individuals with a 
score that falls below this cutoff have responded to the items in a manner that is similar to 
other individuals seeking therapy.  The mean pretreatment and post-treatment ORS scores 
for the clinical cutoff sample were Mpre = 19.44 (SD = 4.49) and Mpost = 31.98 (SD = 
6.95), respectively, producing an observed standardized pre-post mean change of dcutoff = 
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2.79 with a variance of .033.  All analyses utilized critical values with a Type I error rate 
of α = 0.05.  Table 8 presents a comparison of the ES critical value for the clinical cutoff 
sample with the ES critical values observed in PCOMS studies.  
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Table 8 
Critical Value Comparisons for Clinical Cutoff Sample  
 
   Feedback Benchmark 
(group  
PCOMS) 
Feedback Benchmark 
(all  
PCOMS) 
SURP d dcv                p dcv               p 
 
2.79 
 
           0.73          <.001 
 
            0.98         <.001 
Notes.  SURP = Substance Use Recovery Program; PCOMS = Partners for Change 
Outcome Management System; d = [1 - (3/4n - 5)] [Mpost - Mpre/SDpre]; dcv = critical 
effect size value required to attain statistical significance. 
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When the ES for individuals falling below the clinical cutoff (dcutoff = 2.79) was 
compared against the group only PCOMS FB benchmark (dFBgrp = 0.65) with a 10% a 
priori margin (dFBgrp[90%] = 0.59) and a critical value dCV(FBgrp) = 0.73, the observed 
Substance Use Recovery Program ES estimate for those who began treatment below the 
clinical cutoff was considered clinically equivalent (t = 36.38, df = 169, 𝜆 = 7.63, p < 
.001) to the FB treatment outcomes from the two group only PCOMS studies.  The 
estimated effect of the Substance Use Recovery Program sample exceeded the magnitude 
of effect deemed necessary in order to claim at least clinical and statistical equivalence 
with the FB treatment outcomes from the two group PCOMS RCTs.   
Similar results were obtained when the ES for individuals falling below the 
clinical cutoff at the start of therapy was compared to the FB benchmark from all 
PCOMS studies (dFBall = 0.92).   With a 10% a priori margin (dFBgrp[90%] = 0.83) and a 
critical value dCV(FBgrp) = 0.98, the observed Substance Use Recovery Program effect size 
estimate was considered clinically equivalent (t = 36.38, df = 169, 𝜆 = 10.80, p < .001) to 
the established benchmark.  In other words, the estimated effect of the Substance Use 
Recovery Program clinical cutoff sample exceeded the established critical value 
(dCV(FBgrp) = 0.98) necessary in order to claim at least clinical and statistical equivalence 
with the FB treatment outcomes from all PCOMS RCTs.   
Analysis of treatment completers.  A similar supplemental analysis was 
conducted for those individuals (n = 544) who successfully completed the Substance Use 
Recovery Program treatment by attending at least six consecutive therapy sessions and 
obtaining at least two negative drug screens.   The mean pretreatment and post-treatment 
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ORS scores for the treatment completer sample were Mpre = 31.71 (SD = 6.54) and Mpost = 
36.84 (SD = 4.07), respectively, producing an observed standardized pre-post mean 
change of dcompleter = 0.78 with a variance of .003.  All analyses utilized critical values 
with a Type I error rate of α = 0.05.  Please see Table 9 for a comparison of the ES 
critical value for the sample of those who successfully completed treatment with the ES 
critical values observed in PCOMS studies.  
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Table 9 
Critical Value Comparisons for Completer Sample  
 
   Feedback Benchmark 
(group  
PCOMS) 
Feedback Benchmark 
(all  
PCOMS) 
SURP d dcv                p dcv               p 
 
0.78 
 
           0.66            .02 
 
            0.91           0.83 
Notes.  SURP = Substance Use Recovery Program; PCOMS = Partners for Change 
Outcome Management System; d = [1 - (3/4n - 5)] [Mpost - Mpre/SDpre]; dcv = critical 
effect size value required to attain statistical significance. 
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When the ES for individuals who successfully completed treatment (dcompleter = 
0.78) was compared against the group only PCOMS FB benchmark (dFBgrp = 0.65) with a 
10% a priori margin (dFBgrp[90%] = 0.59) and a critical value dCV(FBgrp) = 0.66, the 
observed Substance Use Recovery Program ES estimate for those who completed 
treatment was considered clinically equivalent (t = 18.19, df = 543, 𝜆 = 13.64, p = 0.02) 
to the FB treatment outcomes from the two group only PCOMS studies.  The estimated 
effect of the Substance Use Recovery Program sample exceeded the magnitude of effect 
deemed necessary in order to claim at least clinical and statistical equivalence with the 
FB treatment outcomes from the two group PCOMS RCTs.   
An analysis was also conducted to compare the ES from those who successfully 
completed treatment to the FB benchmark from all PCOMS studies (dFBall = 0.92).   With 
a 10% a priori margin (dFBgrp[90%] = 0.83) and a critical value dCV(FBgrp) = 0.91, the 
observed Substance Use Recovery Program effect size estimate was not considered 
clinically equivalent (t = 18.19, df = 543, 𝜆  =  19.31,  p  =  0.84)  to the established 
benchmark.  In other words, the estimated effect of the Substance Use Recovery Program 
completer sample did not exceed the established critical value (dCV(FBgrp) = 0.91) 
necessary in order to claim at least clinical and statistical equivalence with the FB 
treatment outcomes from all PCOMS RCTs.  
Substance use outcomes.  In regards to substance use outcomes, 48.92% (n = 
544) of the present sample successfully completed treatment, which included obtaining at 
least two negative drug screens.  However, 13.94% (n = 155) of the full sample had to 
restart the Parolee Substance Use Recovery Program due to obtaining a positive drug 
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screen.  A meta-analysis of comparison group studies examining the effectiveness of 
substance abuse treatment conducted by Prendergast, Podus, Chang, and Urada (2002) 
was utilized to compare substance use outcomes.  The meta-analysis was conducted on 
78 treatment-comparison group studies conducted between 1965 and 1996 that examined 
either treatment programs or techniques for substance abuse.  In order to be included in 
the analysis, studies had to include at least one crime or substance use outcome variable.  
Crime use was primarily measured via self-report; however, criminal records were less 
frequently available.  Substance use was measured via self-report, drug testing, or a 
combination of both.  Nearly 80% of the studies included in the analysis utilized an active 
comparison group (i.e., routine treatment, placebo treatment, or alternative treatment) 
while the remainder utilized a passive comparison group (i.e., no treatment, minimal 
treatment, or delayed/wait-list).    
Authors of the meta-analysis utilized the binomial ES display (BESD) as 
developed by Rosenthal and Rubin (1979, 1982) to transform the observed treatment ES 
regarding substance use into a percentage.  The BESD is defined as the percentage of 
study participants in the treatment and comparison groups who achieve a common 
success criterion; this is arbitrarily defined as the median of the scores of the combined 
groups.  It is noted that the overall median should be regarded as a hypothetical 
representation of success rates as criteria for success of treatment is often not available or 
easily defined.  Results of the BESD indicated a 57% success rate for treatment groups 
and a 42% success rate for comparison groups in regards to drug use outcomes.  
Descriptively, the rate of successful completion for the present sample (which includes 
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obtaining two negative drug screens) was higher than the drug use outcome for 
comparison groups, but lower than that observed in the treatment groups. Please see 
Figure 1 for a comparison of the substance use success rates for the present sample and 
the Prendergast et al. (2002) meta-analysis.    
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Figure 1.  Comparison of substance use success rates. SURP = Substance Use Recovery 
Program.   
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Chapter Four: Discussion 
At present, studies examining the effectiveness of group therapy for offenders 
have yielded mixed and inconsistent results (Morgan & Flora, 2002).  Additionally, 
evidence for the efficacy of continuous client feedback within group psychotherapy 
settings is emerging.  Furthermore, a thorough search of the literature failed to find any 
studies that have evaluated the use of a continuous client feedback system with offenders 
referred to attend group treatment.  The present study, to the best of my knowledge, 
presents the first benchmarking analysis of treatment outcomes for offenders referred to 
treatment who utilized a continuous client feedback system as a quality improvement 
strategy.  The benchmarking analyses confirmed one of the four hypotheses.  Results 
revealed the magnitude of change observed in the Substance Use Recovery Program 
sample was not clinically equivalent to the FB benchmark constructed from the two 
PCOMS group RCTs (Hypothesis 1) or to the FB benchmark constructed from all six 
PCOMS RCTs (Hypothesis 2).  Additionally, the ES estimate for the Substance Use 
Recovery Program sample was not determined to be clinically superior to the TAU 
benchmark constructed from only the two PCOMS group studies (Hypothesis 3).  
However, it was determined that the magnitude of change in treatment outcomes 
observed in the Substance Use Recovery Program sample was clinically superior to the 
TAU benchmark constructed from all six PCOMS RCT studies, which included the two 
PCOMS group studies (Hypothesis 4).     
Additionally, preliminary analyses were conducted on the client demographic 
variables of sex category and race/ethnicity.  Treatment outcomes as measured by the 
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pre-post change score were not found to statistically significantly differ based on the 
aforementioned demographic variables.  However, it should be noted that sex and 
race/ethnicity data was missing for 8.2% of the present sample.   
Effectiveness of Client Feedback with Offenders Referred to Treatment 
 Results of the present study examining the effectiveness of continuous 
client feedback for offenders referred to treatment were not clinically equivalent to the 
benchmarks constructed from the FB conditions of RCT studies.  The use of client 
feedback with this particular sample did not produce treatment outcomes similar to those 
observed in rigorous RCTs.  This was similar to the results obtained in Reese et al.’s 
(2014) benchmarking study in which the total sample ES estimate was found to be not 
comparable to the RCTs of PCOMS alone; ES estimates were, however, comparable to 
RCTS of the OQ System and PCOMS combined.  While the observed ES estimate for the 
present full sample was not found to be equivalent to RCTs of PCOMS, it is worth noting 
that the confidence interval for the ES of the full Substance Use Recovery Program 
sample overlapped with the confidence interval for the ES of the FB condition of the 
group PCOMS studies.   
One factor to note in regards to the benchmarking methodology is the use of an a 
priori margin of difference of 10%.  This particular margin was selected for use in the 
present study based on previous research utilizing benchmarking methodology.  While 
the use of a margin of 10% provides a rigorous standard for statistically comparing the 
ES from the naturalistic setting sample with constructed benchmarks from RCTs, it is 
noted that 10% may be objectionable as criteria for establishing comparability to FB 
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conditions and superiority to TAU conditions.  It, perhaps, provides an unfair criterion for 
comparison.  Minami, Wampold, et al. (2008) note that such a criticism “cannot be 
refuted unless the field reaches a consensus on an effect size that would constitute 
comparability (similar to the adoption of α = 0.05 as the criterion for Type I effort rate) 
(p. 122).” 
 Several particular characteristics of the offender population are worthy of noting 
when considering the results regarding client feedback.  It is important to acknowledge 
that the mean ORS pretest score (M = 31.26) for the full sample was well above the 
clinical cutoff score for the measure; a factor that is common for mandated clients, 
according to Miller, Mee-Lee, Plum, and Hubble (2005).  In contrast, for each of the six 
PCOMS studies utilized for the construction of the benchmarks, the mean ORS pretest 
score for the full sample fell below the clinical cutoff of 25.  In fact, the mean ORS 
pretest score for the present sample was larger than the average of the mean ORS post-
test scores from the FB conditions of all PCOMS RCT studies (M = 29.70).  When 
examining only those individuals who started treatment with a pre-test ORS score below 
the clinical cutoff (less than 25), the resulting effects were found to be clinically 
equivalent to the benchmarks constructed from the FB conditions of the two PCOMS 
group studies and the FB conditions from all six PCOMS studies.  This should be 
interpreted with some degree of caution as the benchmarks utilized for comparison to the 
clinical cutoff sample were constructed from the complete samples of the RCTs (not just 
those with a pretest score below cutoff, as such information was not available).     
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There are several possible explanations for the elevated pretest score of the 
present sample when compared to other PCOMS studies.  Because participants in the 
present study were referred to treatment and did not necessarily seek it voluntarily, it is 
plausible that they did not perceive a problem or distress to exist.  In other words, it is 
possible that they would fall into the precontemplation stage of the transtheoretical model 
of motivational readiness.  This particular stage is characterized by a lack of awareness, 
or an under-awareness, that a problem exists.  As reviewed previously, clients falling into 
the precontemplation stage of the transtheoretical model of motivational readiness to 
change are most likely to be clients who entered into therapy because of some external 
pressure (i.e., force from others); in this case, the criminal justice system (Prochaska et 
al., 1992).  Snyder and Anderson (2009) theorize a lack of motivation is potentially a 
normal and expected reaction for precontemplators forced into treatment who experience 
a double bind when acknowledging a problem exists.  This provides one possible 
explanation for the high mean intake score for the present sample.  However, this is only 
speculative as data regarding motivation and stages of change were not provided for the 
present sample.  
 When considering the large mean ORS pretest score, it is also important to 
consider the possibility that participants received mental health treatment while 
incarcerated.  According to a special report by the Bureau of Justice Statistics regarding 
mental health treatment in state prisons (Beck & Maruschak, 2001), one in eight state 
prisoners received some form of counseling services or mental health treatment at 
midyear of 2000.  Additionally, nearly 10% of state prisoners were prescribed 
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psychotropic medication, including antidepressants, stimulants, sedatives, tranquilizers, 
or other anti-psychotic drugs.  As previously noted, Morgan, Winterowd, and Ferrell’s 
(1999) national survey of group therapy in state correctional facilities reported an average 
of 20% of male inmates of responding therapists received some type of group treatment 
while incarcerated.  It is possible that high pretest ORS were partially attributable to 
previous psychotherapy services.  Again, this is only speculative as no information was 
made available regarding previous mental health treatment.    
 Another factor to consider when interpreting the results of the present study is the 
potential double bind that exists for individuals referred to treatment when it comes to 
acknowledging a problem.  Clients referred to treatment may potentially experience a 
desire to minimize distress for fear of how acknowledging a problem may impact their 
standing with the referral source.  For example, a client may fear repercussions from the 
criminal justice system for admitting to struggles with substance use.  Thus, it is possible 
that the client minimizes and underreports problems in order to be viewed by the referral 
source as doing well.  Parolees in the present study may have been experiencing 
psychological distress, but were hesitant to indicate such on the ORS for fear of how such 
an admission would be interpreted or how it would potentially impact their standing on 
parole.  Participants may have experienced a fear that any indication of distress would 
have been reported to the referral source and resulted in undesired consequences.  
According to Mee-Lee, McLellan, and Miller (2010), it is common for mandated clients 
to complete the measures in a manner that indicates little personal, interpersonal, and 
social distress.  Thus, it has been recommended that individuals mandated to treatment 
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complete the outcome measure from the perspective of the referral source (Duncan et al., 
2004).  However, this particular method of administration was not utilized with the 
present sample.  It is important to consider the notion that having the client complete the 
outcome measures from the viewpoint of the referral source could potentially silence the 
client’s own voice, which PCOMS aims to privilege during treatment.   
Also of note, the treatment provided in the present study was found to be 
clinically superior to the TAU conditions of all six PCOMS RCTs, which includes the 
two group PCOMS studies.  This finding suggests that the use of PCOMS with offenders 
who have been referred to attend substance abuse treatment can lead to outcomes that are 
superior to TAU.  This finding is particularly noteworthy given that the data from the 
present study was gathered from a naturalistic setting and represents “real-world” 
treatment with offenders.  The use of a continuous client feedback system privileges the 
client’s voice and enables her or him to provide the clinician with information regarding 
personal well-being and views of treatment progress.  It is speculated that the use of a 
client-directed, outcome informed therapy approach provides the referred client with a 
sense of power and self-determination in an environment in which they otherwise may 
experience coercion and a perceived loss of autonomy.  The use of a continuous feedback 
system may help to address the increased levels of resistance and decreased levels of 
motivation and readiness to change that are characteristic of psychotherapy with coerced 
clients.   
 Results of the supplemental analyses are also noteworthy.  The rate of reliable 
change for the present sample (37.77%) was descriptively larger than the rates observed 
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in the two PCOMS group RCT studies (20.44% for Schuman et al., 2015 and 32.60% for 
Slone et al., 2015).  However, the rate of clinically significant change for the present 
sample (11.60%) was descriptively smaller than those observed in the PCOMS group 
RCTs (28.47% for Schuman et al., 2015 and 41.90% for Slone et al., 2015).  Since the 
mean pretest score for the present sample was well above the clinical cutoff, the 
opportunity to obtain clinically significant change (which includes moving from below 
the clinical cutoff to above it) was not available.  The rate of deterioration for the present 
sample was descriptively larger than that from the Slone et al. study (4.7%), but 
descriptively smaller than that observed in the Schuman et al. study (14.60%).   
Individuals from the Substance Use Recovery Program who successfully 
completed treatment (i.e., attended at least six consecutive sessions and obtained two 
consecutive negative drug tests) obtained outcomes that were clinically equivalent to 
those observed in the FB conditions of the group PCOMS RCTs.  Results were not found 
to be clinically equivalent to those observed in the FB conditions of all PCOMS RCTs.  It 
is important to acknowledge that the two studies utilized to construct the benchmarks 
were based on ITT samples, not completer samples.  Information needed to construct 
benchmarks on completer samples for Schuman et al. (2015) and Slone et al. (2015) was 
not available.  As such, caution should be utilized when interpreting and generalizing the 
results.  This concern can be tempered somewhat by noting the similarity in the number 
of sessions attended by those in the completer sample from the present study (M = 7.06) 
and the average number of sessions attended by participants in the FB conditions of the 
two PCOMS group studies (M = 7.28).    
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 In regards to substance use, the rate of success from the present study was 
descriptively lower than that observed in the treatment groups of a meta-analysis 
examining the effectiveness of substance abuse treatment (Prendergast, Podus, Chang, & 
Urada, 2002).  However, it was descriptively larger than that observed in the comparison 
group from the aforementioned meta-analysis.  This finding suggests group substance 
abuse treatment that utilizes continuous client feedback can result in substance abuse 
outcomes superior to control groups.  Results of the supplemental analyses are notable 
given the characteristics that can impact therapeutic work with such a population.  As 
clients who experience coercion to attend therapy generally have lower levels of 
motivation for treatment and higher levels of resistance than those who voluntarily seek 
treatment, the findings from the supplemental analyses regarding treatment completers, 
substance use rates, and clinical significance are noteworthy.   
Study Limitations 
 Several limitations are noteworthy and need consideration when interpreting the 
results of the present study.  First, the use of a single, brief outcome measure (i.e., the 
ORS) to assess pre-post change limits conclusions.  Although four psychometric studies 
have provided empirical evidence for the reliability and validity of scores generated by 
the ORS, it does not provide the amount of information that a longer outcome measure 
would (e.g., the OQ-45).  However, the brief nature of the ORS makes it more feasible 
for routine use in clinical settings.   
 Treatment fidelity also poses a limitation to the current study.  Attempts were 
made to address this via the implementation of PCOMS trainings, follow-up webinars, 
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and supervision and feedback on the use of the measures.  However, this direct feedback 
regarding the implementation of the outcome system occurred only quarterly to annually 
for clinicians.  As such, it is possible that the outcome management system was not 
utilized as intended.  A potential sporadic use and discussion of the measures, as opposed 
to during every session, may have led to a weakening of the intervention.  No information 
was available regarding clinicians’ reports of treatment fidelity.   
 Relatedly, another limitation of the present study is the modified implementation 
of the outcome measure (i.e., the ORS).  While the measure is designed for each visual 
analog line to be scored to the nearest millimeter, nearly all scores for the present study 
were provided in whole numbers.  Clinicians were instructed to round to the nearest 
centimeter, which resulted in whole number scores.  Treatment providers were instructed 
by the PCOMS trainer to utilize this method to add to the feasibility and simplicity of 
scoring and recording.  As previously mentioned, a modified administration method was 
used in the Miller, Duncan, Brown, Sorrell, & Chalk (2006) study in which PCOMS was 
administered over the telephone.  Results should be interpreted with some caution as 
psychometrics regarding modified administrations have not been examined.   
In regards to the benchmarking methodology, several limitations are of note.  
While the outcome measures utilized were identical, and thus matched on reactivity and 
specificity, the samples being compared were not identical.  With the exception of the 
sample from Schuman et al. (2015) that included individuals who were primarily referred 
for substance abuse treatment, the samples from the studies utilized to construct the 
benchmarks primarily sought treatment on a voluntary basis.  As no studies examining 
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the efficacy of PCOMS with offenders exist in the literature, a best effort of equivalence 
was utilized.     
Additionally, no RCT studies examining the effectiveness of cognitive-behavioral 
therapy (CBT) based substance abuse treatment for offenders were found that used a 
comparable outcome measure.  RCTs that were examined for inclusion focused primarily 
on drug use or diagnosis specific outcomes, as opposed to global assessments of well-
being.  Snyder and Anderson (2009) noted several methodological shortcomings within 
the literature on mandated substance abuse, including differences in outcomes measure, 
differences in comparison groups, and inconsistencies in what constitutes mandated 
therapy, that hindered the comparison of RCTs with the present study.  Other research 
syntheses regarding both group substance abuse treatment and general group treatment 
for offenders were examined for possible inclusion in construction of a benchmark.  
However, comparable studies were not found due to a lack of RCT design, differences in 
population and focus of the groups, and lack of use of similar outcome measures.  Thus, 
only feedback benchmarks were used for comparison in the present study.    
Implications and Future Recommendations 
The present study, which is the first to examine the use of PCOMS with a sample 
of offenders, expands our understanding of the use of a continuous client feedback 
system with individuals referred to treatment.  Despite the documented success in 
treatment outcomes regarding the use of continuous client feedback with voluntary 
clients, results of the present study suggest differences in effectiveness with individuals 
referred to treatment.  Although ES estimates from the present sample were not found to 
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be equivalent to those observed in the FB conditions of RCTs utilizing PCOMS, 
treatment provided was found to be clinically superior to the TAU ES estimate from all 
six PCOMS studies, including two conducted with groups.  This finding suggests the use 
of a continuous client feedback system with such a sample can be effective, but requires 
further understanding of the nuances regarding referred treatment with offenders.  
Particular characteristics of offender populations, including decreased motivation for 
treatment and increased resistance to change when compared to individuals who 
voluntarily seek services, may have influenced the observed outcomes.  Findings of the 
present study provide evidence for the continued exploration of the effectiveness of 
continuous client feedback with offenders referred to treatment.   
One noteworthy finding from the current study is the high mean pretest score 
from the present sample, particularly when compared to the mean intake scores from the 
six PCOMS RCTs.  This appears to support previous reports that clients referred to 
treatment will complete the measures in a manner that indicates low levels of distress 
(Mee-Lee et al., 2010).  Findings suggest that the use of client feedback with such a 
population poses certain concerns that could benefit from being addressed in future 
research.  For example, future studies could examine the implementation of the feedback 
system when offenders are asked to complete the measures from the viewpoint of the 
referral source.     
As was previously mentioned, no current RCT study exists to examine the 
efficacy of a client feedback system with offenders who have been referred to treatment.  
Based on the unique characteristics of such a sample, and the findings from the present 
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study, such an examination appears warranted.  Implementing measures of client 
readiness to change, as well as an assessment of perceived coercion to treatment, would 
also help to add to the understanding of treatment outcomes with this particular 
population.  Relationships between perceived coercion, motivation for treatment, client 
resistance, and treatment outcomes could be examined in order to better understand the 
impact of continuous client feedback on known characteristics of psychotherapy with 
coerced clients.   
Additionally, given the findings of the present study, it is recommended research 
continue to examine the effects of continuous client feedback utilizing benchmarking 
methodology.  As benchmarking allows for a comparison of the effectiveness of real-
world, naturalistic treatments with gold standards of care observed in rigorous RCTs, it is 
recommended that the present study be replicated with other referred samples.  The 
present study provides methodological guidance for the continued evaluation of the 
effectiveness of psychotherapy in real-world settings.  As the present sample was 
composed primarily of males, research examining the effects of client feedback with 
female offenders referred to treatment would help to increase understanding of the unique 
characteristics of such a population.  Research could also examine the effectiveness of 
continuous client feedback systems with juvenile offenders and offenders referred to 
therapy for specific concerns (e.g., sex offender treatment, anger management, domestic 
violence, etc.).  As the present study focused on group treatment, it would also be 
informative for future research to examine the use of continuous client feedback with 
offenders in individual settings.    
 
 
 
 97 
Conclusions 
 The present study helps to expand our understanding of the effectiveness of 
continuous client feedback, particularly with individuals who have been referred to 
treatment.  Though results were not found to be clinically equivalent to those observed in 
the FB conditions from RCTs, they were found to be clinically superior to treatment as 
usual for all PCOMS studies.  Several known characteristics of coerced psychotherapy, 
including client resistance and motivation for treatment, may have impacted the observed 
treatment outcomes from the current study.  Results indicate a difference in effectiveness 
for the use of continuous client feedback with individuals referred to treatment, as 
opposed to those who voluntarily seek services.  Further research is needed to better 
understand the use of a feedback system with such a sample.  However, findings from the 
present study suggest that it may be beneficial in producing outcomes superior to 
treatment as usual.   
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Appendix A 
Outcome Rating Scale (ORS) 
 
Outcome Rating Scale (ORS) 
 
 
 
Name ________________________Age (Yrs):____ 
ID# _________________________ Sex:  M / F 
Session # ____  Date: ________________________ 
 
Looking back over the last week, including today, help us understand how you have been 
doing in the following areas of your life, where marks to the left represent low levels and 
marks to the right indicate high levels. 
 
 
 
Individually: 
(Personal well-being) 
 
I----------------------------------------------------------------------I 
 
Interpersonally: 
(Family, close relationships) 
 
I----------------------------------------------------------------------I 
 
Socially: 
(Work, School, Friendships) 
 
I----------------------------------------------------------------------I 
 
Overall: 
(General sense of well-being) 
 
I----------------------------------------------------------------------I 
 
 
 
Institute for the Study of Therapeutic Change 
_______________________________________ 
www.talkingcure.com 
 
© 2000, Scott D. Miller and Barry L. Duncan 
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Appendix B 
PCOMS Graph 
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